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Dual-energy X-ray absorptiometry 
(DXA) is commonly used to 
diagnose osteoporosis. Overweight 
is considered to confer protection 
against from osteoporosis, but 
DXA devices may be subject to 
systematic errors when they are 
measuring overweight individuals. 
This study aimed to assess how 
obesity can affect bone mineral 
measurements.
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ABSTRACT 
 
Measurement of bone mineral density (BMD, g/cm2) by dual-energy X-ray absorptiometry 
(DXA) is the clinical golden standard technique with which to diagnose osteoporosis. In 
general, overweight is considered to confer protection against from osteoporosis and 
conversely underweight is considered as a major risk factor for osteoporosis and low-
energy fractures. Many biological mechanisms have been proposed to explain this positive 
relationship between adiposity and bone tissue. However, the strong connection between 
DXA-measured BMD and anthropometric parameters has been called into some question 
due to the systematic errors inherent in planar DXA technology. 
The present thesis evaluated the effects of adiposity on DXA and quantitative ultrasound 
(QUS) measurements in postmenopausal women. This study population consisted of 
stratified samples from both the Kuopio Osteoporosis Risk Factor and Prevention study 
(OSTPRE) and its Fracture Prevention substudy (OSTPRE-FPS) study cohorts. Eighty-nine 
women were measured twice with two different DXA devices in a cross-calibration study. 
In addition 139 women were measured cross-sectionally with QUS, peripheral DXA 
(pDXA) and central DXA devices. The effect of central obesity on BMD values was studied 
on a sample of 198 women. The association between progress of bone loss and obesity was 
studied in a sample of 300 women, who underwent BMD and body mass index (BMI) 
measurements three times during a mean follow-up of 10.5 years. 
There were systematic differences between the measurement values of two pencil-beam 
DXA densitometers (DPX and DPX-IQ) from the same manufacturer, although their 
correlation was high. The DPX measured BMD values were higher for lumbar spine and 
Ward’s triangle, whereas femoral neck BMD results were lower compared to DPX-IQ. In all 
regions of interests (ROI), the regression slope was significantly different from unity, thus 
demonstrating the need for cross-calibration between the two densitometers. With most 
ROI’s, except for lumbar spine, the performance of the two devices was also found to 
depend on BMI or weight, thus affecting correction equations during cross-calibration. 
A positive trend, although not always statistically significant, was found between the 
body size (height) and most of the measured QUS and DXA bone parameters. DXA, pDXA 
and QUS parameters were differently affected by adiposity. Thus, higher heel and lumbar 
spine BMD values were observed with increasing adiposity, whereas femoral neck BMD 
values and some of the QUS parameters were less affected by adiposity. There were 
inconsistencies between the study population-based normalized values (z-scores) and the 
manufacturer provided T-score values between the different devices. 
DXA measured trunk fat and weight were the strongest determinants of postmenopausal 
lumbar spine and femoral neck BMD, respectively. DXA-measured trunk fat was positively 
VI 
 
 
associated with spinal BMD, but not with femoral neck BMD. This positive association was 
also present regardless of the use of hormone therapy (HT). 
Obesity was associated with a higher BMD and it may delay the incidence of osteopenia 
considerably. On the average, women with a BMI of 20 kg/m2 became osteopenic at the 
spine 2 years and at the femoral neck 4 years after menopause, whereas women with a BMI 
of 30 kg/m2 only became osteopenic approximately 5 (spine) and 9 (femoral neck) years 
later. 
The association between adiposity and DXA measurement values found here may be 
explained by both biological and methodological factors. Adiposity may affect the cross-
calibration results of DXA densitometers. Adiposity and different normative values may 
explain at least in part the discrepancies between central DXA, pDXA and QUS 
measurements. Trunk fat may be positively associated with spinal BMD values. Obesity 
delayed the occurrence of osteopenia in postmenopausal women. 
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TIIVISTELMÄ 
 
Kaksienerginen röntgenabsorptiometria (DXA) on luun mineraalitiheyden (BMD) 
mittaamisen kultainen standardi. Ylipaino suojelee yleensä luukadolta, kun taas alipaino on 
merkittävä luukadon ja matalaenergisten murtumien riskitekijä. Monet biologiset tekijät 
selittävät rasvakudoksen ja luun positiivista yhteyttä. Kuitenkin DXA-tekniikalla mitattujen 
BMD-arvojen ja antropometristen muuttujien välinen vahva yhteys on osittain 
kyseenalaistettu DXA-tekniikkaan luontaisesti liittyvien systemaattisten virheiden takia. 
Tässä väitöskirjassa tutkittiin rasvakudoksen vaikutusta DXA ja kantaluun QUS-
ultraäänimittauksiin naisilla vaihdevuosien jälkeen. Tutkimusaineisto pohjautuu Kuopion 
Osteoporoosin vaaratekijät ja ehkäisy -tutkimuksen (OSTPRE) sekä sen alaisen 
murtumanestotutkimuksen (OSTPRE-FPS) kohortteihin. 89 naiselta mitattiin luuntiheydet 
kahdella eri luuntiheysmittarilla ristiinkalibrointitutkimuksessa. 139:ltä naiselta mitattiin 
poikkileikkaustutkimuksessa luuntiheydet sekä kantaluusta ultraääni- ja perifeerisellä 
DXA-tekniikalla että lannerangasta ja lonkasta DXA-menetelmällä. Keskivartalolihavuuden 
vaikutusta luuntiheysarvoihin tutkittiin 198 naisen otoksella. Keskimäärin 10,5 vuoden 
seuranta-aikana mitattiin luuntiheys, pituus ja paino kolmesti 300:n naisen otoksesta, 
tarkoituksena tutkia luuntiheyden menetysnopeutta eri painoisilla naisilla. 
Kahden kynäkeilatekniikkaa hyödyntävän DXA-laitteen (DPX ja DPX-IQ) 
mittaustuloksissa havaittiin systemaattisia eroja, vaikka näiden saman valmistajan laitteilla 
saatujen mittaustulosten välinen korrelaatio olikin korkea. Verrattuna DPX-IQ laitteeseen, 
DPX-laitteen mittaamat arvot olivat korkeampia lannerangan ja Ward’n kolmion ja 
matalampia reisiluunkaulan luuntiheyksien osalta. Kaikissa mittauskohteissa laitteiden 
ristiinkalibrointi on välttämätöntä, koska regressiokäyrät poikkesivat tilastollisesti 
merkittävästi toisistaan. Lähes kaikissa mittauskohdissa, paitsi lannerangassa, painon tai 
painoindeksin vaikutus piti huomioida ristiinkalibroinnissa ja korjauskertoimia 
laskettaessa. 
Positiivinen yhteys havaittiin kehon koon (pituus) ja lähes kaikkien QUS- ja DXA-
parametrien välillä, vaikka positiivinen yhteys ei ollutkaan aina tilastollisesti merkitsevä. 
Ainoastaan kantaluumittauksien äänennopeusarvoihin (SOS) tai lannerangan BMD-
arvoihin kehon koko ei vaikuttanut. Rasvakudos vaikutti eri tavoin sekä kantaluun 
ultraääni (QUS) ja perifeeriseen DXA-mittaukseen (pDXA) että lannerangan ja lonkan DXA 
mittaustuloksiin. Havaitsimme korkeampia luuntiheysarvoja etenkin kantaluussa ja 
lannerangassa ylipainoisilla naisilla. Reisiluunkaulan luuntiheysarvot ja osa kantaluun 
ultraäänimittausten tuloksista oli sen sijaan vähemmän riippuvaisia rasvakudoksen 
määrästä. Myös eri laitteiden välillä havaittiin epäsuhta tutkimusväestöstä saatujen 
normalisoitujen (z-score) ja laitevalmistajan (T-score) viitearvojen välillä.  
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DXA-laitteella mitattu ylävartalon rasvakudos selitti parhaiten lannerangan luuntiheyttä 
ja paino parhaiten reisiluunkaulan luuntiheyttä naisilla vaihdevuosien jälkeen. DXA-
laitteella mitatun ylävartalon rasvakudoksen ja lannerangan luuntiheyden välillä oli 
merkittävä positiivinen yhteys, mutta keskivartalolihavuus ei vaikuttanut reisiluunkaulan 
luuntiheysarvoihin. Positiivinen yhteys DXA-laitteella mitatun keskivartalolihavuuden ja 
lannerangan luuntiheyden välillä säilyi vaihdevuosien hormonikorvaushoidon (HT) 
käytöstä riippumatta. 
Ylipainoisilla ja lihavilla naisilla havaittiin korkeampi luuntiheys vaihdevuosien jälkeen 
kuin ali- ja normaalipainoisilla. Lihavuus hidasti osteopenian ilmaantumista vaihdevuosien 
jälkeen: normaalipainoisten (painoindeksi, BMI=20 kg/m2) naisten luuntiheysarvot 
heikentyivät keskimäärin osteopeeniselle tasolle lannerangassa 2 vuotta ja 
reisiluunkaulassa 4 vuotta vaihdevuosien jälkeen, kun taas lihavien naisten (BMI=30 kg/m2) 
luuntiheyden heikkeneminen osteopeeniselle tasolle viivästyi keskimäärin 5 vuotta 
lannerangassa ja 9 vuotta lonkassa. 
Sekä biologiset että metodologiset syyt selittivät rasvakudoksen ja DXA-mittausten 
yhteyttä. Rasvakudos voi vaikuttaa DXA-laitteiden ristiinkalibrointiin. Rasvakudos ja 
erilaisista väestöistä saadut viitearvot selittävät osittain eroavaisuuksia kantaluun DXA-
mittausten, sentraalisten DXA-mittausten ja kantaluun ultraäänimittausten välillä. Vartalon 
rasvakudoksen ja lannerangan luuntiheysarvojen välillä oli positiivinen yhteys. 
Vaihdevuodet ohittaneilla naisilla lihavuus viivästyttää osteopenian ilmaantuvuutta. 
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1 Introduction  
Two chronic disorders related to body composition, osteoporosis and obesity, are 
increasing in prevalence and thus their interactions are of the utmost public health interest 
(Rosen, Bouxsein 2006). The prevalence of osteoporosis has risen to 20% among Caucasian 
postmenopausal women (Kanis et al. 2008c). 
Screening for osteoporosis is complicated by the dual nature of overweight; it is both a 
major biological bone protective factor and a source of DXA measurement error (Bolotin 
2007, Looker, Flegal & Melton 2007). Increasing tissue thickness as well as the presence of 
non-homogenous and homogenous soft tissue adjacent to bone may alter X-ray attenuation, 
resulting in a measurement artifact (i.e. there may not be any real change in bone density) 
(Bolotin 2007). 
However, there are biological reasons to explain why overweight can actually protect 
from osteoporosis. First, excess body weight predisposes the body to mechanical loading, 
which is crucial for bone health (Seeman, Delmas 2006, Greene et al. 2012). Second, in 
postmenopausal women, the aromatization of androgens into estrogens occurs in lean and 
fat tissue and is the major source of natural estrogen which may explain some of the 
positive relationship between postmenopausal bone density and body weight (Douchi et al. 
2000b, Liedtke et al. 2012). Third, adiposity regulating hormones have clear effects on BMD; 
leptin is associated positively with BMD, whereas adiponectin shows a negative 
relationship (van der Velde et al. 2012). Finally, obese postmenopausal women exhibit a 
more androgenic hormone profile than their lean postmenopausal counterparts, which may 
also link BMD with obesity (Clarke, Khosla 2009, Liedtke et al. 2012). Importantly, the 
greater soft tissue padding around the greater trochanter in overweight women diminishes 
impact forces experienced during a fall and thus this can reduce the incidence of pelvis and 
hip fractures (Bouxsein et al. 2007, Beck et al. 2009). 
The diversity of different techniques, devices and parameters complicates the selection of 
optimal screening machinery. The results of DXA densitometry as measured with 
equipment from different manufacturers or even with similar devices from the same 
manufacturer, may differ significantly due to technical differences, unexpected changes in 
the way equipment is calibrated and different normative values (Blake, Fogelman 2009, 
Malouf et al. 2012). 
It is not clear whether adiposity affects the cross-calibration of different DXA devices. 
Furthermore, it is not known whether fat tissue is responsible for the differences 
encountered between QUS and DXA devices. In addition, the number of long-term follow-
up studies evaluating the association between obesity and bone mineral measurement is 
limited. Finally, there is contradictory evidence between the association of central obesity 
and bone mineral measurements. This study was conducted to examine the relationship 
between adiposity and bone mineral measurements in postmenopausal women as a part of 
the Kuopio Osteoporosis Risk Factor and Prevention (OSTPRE) and Fracture Prevention 
(OSTPRE-FPS) studies. 
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2 Review of the Literature 
2.1 OSTEOPOROSIS AND BONE LOSS 
2.1.1 Definition of osteoporosis 
Osteoporosis is defined as a skeletal disorder characterized by compromised bone strength 
(density and quality) predisposing to an increased risk of fracture (NIH Consensus 
Statement 2000). In 1994, World Health Organization (WHO) defined osteopenia according 
to the T-score ((measured BMD – mean reference peak young adult BMD) / 1 standard 
deviation (SD) of the peak young adult reference population) thresholds of between 2.5 and 
1.0 SD below the healthy young adult mean at the spine, hip or radius measured with DXA 
(Lewiecki et al. 2008). Osteoporosis was defined by a T-score threshold of more than 2.5 SD 
below the healthy young adult mean. The established osteoporosis requires one or more 
fragility fractures in addition to the normal definition of osteoporosis. One SD is about 10–
15% of the mean BMD and bone size differs by 50% in individuals at the 95th and 5th 
percentiles. The variance (1 SD) in the rate of bone loss corresponds to a 1% bone loss of the 
mean (Wang, Seeman 2008). However, in premenopausal women, the International Society 
for Clinical Densitometry (ISCD) recommends the use of Z-scores (measured BMD – mean 
age-matched reference BMD / age-matched population SD) rather than T-scores (Lewiecki 
et al. 2008). 
It may be advantageous to use the Z-score also in elderly individuals because a high 
proportion of them are classified as osteoporotic according to T-score criteria, even when 
BMD is normal for age (Steel, Peel 2011). The use of T- and Z-score normalizations reduce 
bias, eliminate a constant calibration offset and reduce patient-dependent systematic errors, 
such as fat errors (Engelke, Glüer 2006). However, the difficulty in determining reference 
peaks, means and SDs is a significant weakness of the T-score approach (Lu et al. 2001). In 
addition, the problem with clinically important T-score values is that the measurements are 
performed with different devices from different manufacturers and/or ROI’s and thus 
applying different reference populations for normalization (Leslie, Caetano & Roe 2005, 
Blake, Fogelman 2009). National Health and Nutrition Examination Survey (NHANES) is 
superior to manufacturers’ reference data due to the large size of the study and 
representative cross-section of the population sampled (Binkley et al. 2005, Leslie, Caetano 
& Roe 2005). However, the use of Swedish reference values as compared with 
manufacturers’ and NHANES III reference populations has lead to a two-fold increase in 
the prevalence of postmenopausal osteoporosis (Ribom, Ljunggren & Mallmin 2008). In 
addition, different exclusion and inclusion criteria as well as inadequate sample size of 
reference populations may lead to super healthy population and an artificially small 
population variance (SD) (Bhandari et al. 2003). Furthermore, regional differences for the 
same race and gender, racial differences, the onset of menopause (variation with age), 
height and body weight (especially in extreme cases) should be taken into account when 
assembling reference data (Engelke, Glüer 2006). When T-scores are used, any inaccuracy in 
the measurement of SD is multiplied by 2.77 (√2 x 1.96, where 1.96 (95% confidence level) is 
from the z-probability table) times in setting the threshold for the definition of osteoporosis 
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(Blake, Fogelman 2007, Badrick, Hickman 2008). T- and Z-scores may differ significantly in 
women under the age of 50 years (Carey et al. 2007). 
According to ISCD, the non-dominant femoral neck is considered the most suitable ROI 
for predicting osteoporosis (Lewiecki et al. 2008), whereas lateral spine and Ward’s triangle 
overestimate prevalence of osteoporosis (El Maghraoui, Roux 2008). Anteroposterior (AP) 
spine is the optimal ROI with which to follow-up the response to osteoporosis treatment 
(Blake, Fogelman 2009). The nondominant forearm ROI is recommended in very obese 
patients (who exceed the body weight limitation of the DXA table) (Simonelli et al. 2008). 
Each SD reduction at the hip and spine is associated with a 2.9-fold and 2.3-fold increased 
risk of hip and spine fracture, respectively (Johnell et al. 2005, Kanis et al. 2008c). Thus, for 
example a woman with a hip T-score of -3 would have a 24.4-fold (i.e. 2.93) increase in 
probability of suffering hip fracture compared to a T-score of 0. The use of cumulative 
clinical risk factors enhances the performance of BMD in the prediction of fractures 
considerably (Kanis et al. 2007, Waris et al. 2011). 
Thirty-five to 45 percent of 50 year old women, 49-52% of 60 year old women, 55-64% of 
70 year old women and around 49% of 80 year old women may exhibit osteopenia, 
respectively (Kanis et al. 2008c). The prevalence of osteoporosis is greater among the female 
population and increases with advancing age. Thus, 2-6% of the 50 year old women, 6-11% 
of the 60 year old women, 17-20% of the 70 year old women, 33-45% of the 80 year old 
women and 49-73% of the 90 year old women may exhibit osteoporosis, respectively (Kanis 
et al. 2008c). However, there have been concerns about the overdiagnosis and 
overtreatment of osteoporosis (Moynihan, Doust & Henry 2012). Osteoporosis and 
subsequent fragility fractures are associated with excess mortality, morbidity and extensive 
medical care costs (Lim et al. 2009). According to, NHANES 2005-2006, 49% of women and 
30% of men aged 50 years or older suffered from osteopenia and 10% of women and 2% of 
men had osteoporosis at the femur neck, respectively (Looker et al. 2010). The lifetime risk 
of any osteoporotic fracture for women is about 40 to 50% (Johnell, Kanis 2005). However, 
non-osteoporotic women can also suffer a low trauma fracture (Stone et al. 2003, Schuit et 
al. 2004, Wainwright et al. 2005). Thus, not all women with low BMD will actually sustain a 
fracture (Kanis et al. 2012). For example, only 10 to 44% of women who suffered a fragility 
fracture were osteoporotic, whereas more than half of fragility fractures occurred in non-
osteoporotic women (Stone et al. 2003, Schuit et al. 2004, Wainwright et al. 2005). Thus, 
most fragility fractures occur in osteopenic women due to their relatively higher 
prevalence, whereas osteoporotic women have higher absolute fragility fracture risk. For 
example, a tendency to fall should not be overlooked as a risk factor for causing fractures 
(Merilainen et al. 2002). 
 
2.1.2 Pathogenesis of osteoporosis 
Cortical bone accounts for 70-80% of the mass of bone in the human body and 80-90% of 
cortical bone is calcified. However, most of the bone surface area (80%) consists of 
trabecular bone, but only 15-25% of trabecular bone is calcified and the remaining volume 
contains bone marrow, connective tissue or adipose tissue. Bone consists of several 
inorganic (60% of the bone dry weight is bone mineral, i.e. hydroxyapatite or 
Ca10(PO4)6(OH2)) and organic (40% of the dry weight, mainly type 1 Collagen) molecules. 
Bone mineral homeostasis is controlled by four hormones, i.e. parathyroid hormone (PTH), 
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1,25-dihydroxycholecalciferol, calcitonin, fibroblast growth factor-23 (Fleet, Schoch 2010, 
Civitelli, Ziambaras 2011). In adult bones, the annual turnover rate of the whole skeleton is 
about 10%, whereas the annual renewal rate of cortical and trabecular bone is 3% and 25%, 
respectively. Bone remodeling regulates both mineral homeostasis (e.g., calcium and 
phosphorus) and renews old bone and their mechanical properties. Bone remodeling units 
work in four coupling phases: activation, resorption (osteoclasts, 1-3 weeks), reversal and 
formation (osteoblasts, 3-4 months) (Seeman 2008a). Osteoporotic bone is characterized by 
cortical and trabecular thinning as well as increased porosity (Armas, Recker 2012). There is 
a decrease in normal bone formation during the low-turnover age-dependent bone loss 
(type 2 osteoporosis), whereas, the high-turnover state of postmenopausal bone loss is 
characterized by both abnormal bone formation and resorption (type 1 osteoporosis) (Syed, 
Ng 2010). Furthermore, as the bone is removed from the inner endosteal surface, concurrent 
new bone formation appears on the outer periosteal bone surface, thus increasing the 
bone’s cross-sectional area and bone strength. This periosteal apposition is less in women 
than men, thus increasing their susceptibility to fractures (Seeman 2008b). As compared to 
women, men have a larger number of thicker trabeculae and thicker cortices in both tibia 
and radius (Macdonald et al. 2011). Thus, a bone with a thicker cortical width will resist 
fractures compared to bones with less thick cortical width (Webber 2006). 
Fifteen percent of the life time cortical bone loss occurs before the age of 50, whereas the 
corresponding trabecular bone loss is 40% (Riggs et al. 2008). Estrogen-depletion seems to 
promote especially cortical bone loss, whereas the trabecular bone loss which begins in 
young adults is partly estrogen-independent (Khosla, Melton & Riggs 2011). Thus, 
trabecular bones may be less sensitive to estrogen, but also higher estrogen levels are 
needed to preserve trabecular bone (Khosla, Melton & Riggs 2011). From an evolutionary 
perspective, calcium reserves are liberated predominantly from trabecular bone, whereas 
cortical bone is protected and reserved to carry skeletal load and support locomotion 
(Khosla, Melton & Riggs 2011). Estrogen deficiency in postmenopausal women, but also 
oxidative stress factors plays a role in the pathogenesis of osteoporosis (Manolagas 2010). 
 
2.1.3 Menopause, hormone therapy (HT), body composition and osteoporosis 
Menopause is the time of life when the menstrual cycles cease and it is classified as being 
present after 12 months of amenorrhoea resulting from the permanent cessation of ovarian 
function either naturally or surgically (ovariectomy). The perimenopause, a time of 
deteriorating ovarian function, precedes the final menses by several years (Harlow, 
Paramsothy 2011). The natural onset of perimenopause and menopause occurs on an 
average at between 47.5 and 51.3 years in western societies, respectively (McKinlay, 
Brambilla & Posner 2008). The menopausal transition is associated with increased adiposity 
and central obesity as well as sarcopenia especially in the gluteal and abdominal areas 
(Salpeter et al. 2006). Typically a woman will gain a few kilograms during the first 
postmenopausal years; however it has been proposed that age better determines the 
changes in body composition than menopausal transition (Sornay-Rendu et al. 2012). 
Menopause is associated with a decrease of 65-75% in levels of estrone, 85-90% in 
estradiol and 70% in adrenal androgen concentrations (Clarke, Khosla 2010, Yasui et al. 
2012). HT, i.e. estrogen treatment with or without progestogen, is primarily used to treat 
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the symptoms of menopause such as hot flashes and urogenital atrophy (Santen, Allred et 
al. 2010). 
A Cochrane meta-analysis has indicated that estrogen with a progestogen increased the 
risk of breast cancer, death from lung cancer, coronary heart disease and dementia, whereas 
combined HT and estrogen-only therapy were associated with an increased risk of venous 
thromboembolism, stroke and gallbladder disease (Marjoribanks et al. 2012). Estrogen use 
alone for less than 5 years may even reduce breast cancer risk in patients starting therapy 
many years after the onset of menopause, whereas estrogen use for over 5 years is believed 
to increase the breast cancer risk, particularly in recently postmenopausal women (0-
2.59/1000) (Santen, Allred et al. 2010). Combined HT was associated with an increased risk 
of breast cancer 3-5 years after the initiation of therapy, but not after 5 years of combined 
HT use (Santen, Allred et al. 2010). However, Santen et al. found no association between HT 
and lung cancer risk (Santen, Allred et al. 2010). Estrogen alone may also increase the 
ovarian cancer incidence (0.7/1000/5 year use), and furthermore estrogen alone may 
increase endometrial cancer risk but this does not occur if sufficient doses of progestogen 
are used (Zhou et al. 2008, Crosbie et al. 2010, Santen et al. 2010). The Cochrane meta-
analysis found no association between HT, colorectal cancer, ovarian cancer and 
endometrial cancer incidence (Marjoribanks et al. 2012). 
HT may also reduce gastric cancer incidence and combined HT may also decrease the 
risk of colorectal cancer (Camargo et al. 2012). Estrogen combined with drospirenone 
(progestogen) is at least weight neutral or may be even associated with weight loss (Foidart, 
Faustmann 2007). Santen’s group concluded that HT could reduce body weight, FM and 
abdominal obesity, and thus it reduces the type II diabetes and degenerative arthritis risk 
(Santen, Allred et al. 2010). Postmenopausal HT reduces abdominal obesity and preserves 
muscle strength (Salpeter et al. 2006, Jacobsen et al. 2007). Fortunately, it is believed that the 
breast cancer risk normalizes 5 years after withdrawal of estrogen alone and 3 years after 
cessation of combined HT (Santen, Allred et al. 2010). 
Estrogen affects both proliferation and apoptosis of osteoblasts and osteoclasts. Estrogen 
suppresses tumor necrosis factor-α as well as decreasing receptor activator of nuclear factor 
kappa-B-ligand (RANK-ligand) activation by elevating osteoprotegerin (OPG) levels 
(Legiran, Brandi 2012). Postmenopausal estrogen and combined HT prevent early 
postmenopausal bone loss and augments late menopausal bone mass as effectively as 
bisphosphonates (Marjoribanks et al. 2012). There are reports that HT can also reduce the 
incidence of vertebral fractures that occur after menopause by up to 34% and those of hip 
fractures by 20-35% (Cranney et al. 2002, Nelson et al. 2010a). However, it seems that 
withdrawal of HT treatment results in a rapid increase of bone turnover and a rate of bone 
loss similar to early postmenopausal women and is associated with an increased risk of hip 
fracture (Simon et al. 2006, Karim et al. 2011). 
The Current Care guideline (Käypä hoito) of the Finnish Medical Society Duodecim 
recommends HT for the treatment of osteoporosis in patients with primary and secondary 
amenorrhea (over 1 year duration of amenorrhea) or in patients with early menopause 
before the age of 45 years (Välimäki et al. 2006). Current Care guideline task force group 
has suggested that HT may be continued up to 50 years of age (Välimäki et al. 2006). 
According to the National Osteoporosis Society of the United Kingdom HT has a role to 
play in the management of osteoporosis in women less than 60 years of age (Bowring, 
Francis 2011). However, the risks and benefits as well as the duration of HT need to be 
7 
 
 
 
carefully assessed before initiation of prevention or treatment of osteoporosis (Staren, Omer 
2004). 
2.1.4 Peak bone mass and natural progress of bone loss 
Bone mass is acquired during childhood and adolescence and the peak bone mass is 
achieved in early adulthood (Winsloe et al. 2009). The accrual of spinal and femoral peak 
bone mass varies but normally occurs between 16-36 and 29-40 years, respectively (Tamayo 
et al. 2009, Berger et al. 2010). Once peak bone mass has been reached, there is a progressive 
decrease in BMD with advancing age (Riggs et al. 2008). Heritability explains 50-85% of the 
variability in peak BMD (Ralston, Uitterlinden 2010). Postmenopausal status and low body 
weight are best at predicting low BMD and the risk of osteoporosis (Waugh et al. 2009). 
During the first perimenopausal years, women may lose annually up to 2 to 4% of their 
acquired spinal BMD (Mazzuoli et al. 2000, Finkelstein et al. 2008). Women lose around 15% 
of total spinal BMD during the first 6 menopausal years (Mazzuoli et al. 2000). The most 
rapid phase of spinal bone loss ceases around 2 years after menopause, but continues at a 
considerable rate to 6-10 years after menopausal transition (Greendale et al. 2012). The 
typical postmenopausal spinal bone loss rate varies from 0.5 to 2% per year (Finkelstein et 
al. 2008, Ghebre et al. 2011). Spinal bone loss rate seems to slow down or even to plateau in 
elderly women (Araneta, von Muhlen & Barrett-Connor 2009, Looker et al. 2012c). AP 
lumbar spine BMD values may even increase in elderly women due to degenerative 
changes (Liao et al. 2003). Femoral neck bone loss is instead rather more linear with an 
annual bone loss rate varying from -0.4 to -1.4% (Araneta, von Muhlen & Barrett-Connor 
2009, Looker et al. 2012b). In contrast trochanter bone loss rate is quite slow, ranging from -
0.2 to -0.5%/year between 35 and 75 years of age (Kudlacek et al. 2003, Pedrazzoni et al. 
2003). Furthermore, the trochanter bone loss rate is slower in Caucasian women than in 
other races (Wu et al. 2003). However, it is not known if this reflects the true preservation of 
the trabecular bone. Typical femoral neck, lumbar spine and trochanter BMD values in 
different age groups are depicted in figure 1. 
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Figure 1. Femoral neck, lumbar spine and trochanter BMD values according to the Densitometric Italian Normative Study 
(DINS, n=1622) and the NHANES (2005-2008, white women, n=1777-1928) using Hologic DXA devices in different age 
groups (Pedrazzoni et al. 2003, Looker et al. 2012a). Lumbar spine ROI: L2-4 (DINS) and L1-4 (NHANES). 
 
2.2 BONE DENSITOMETRY 
2.2.1 Bone densitometric techniques 
The diagnostic approach to osteoporosis includes a general examination, AP and lateral 
radiographs of the thoracic and lumbar spine and of other sites during bone pain (crush 
fractures), laboratory tests (secondary causes) and bone mineral measurements (Hudec, 
Camacho 2013). The development of bone imaging techniques has made major advances 
during the past few decades. Multidetector and high resolution quantitative computed 
tomography (CT) and magnetic resonance imaging (MRI) provide information of the 
macro-architecture of bone as well as of trabecular and cortical microarchitectural bone 
structures (Griffith, Genant 2008). However, central DXA, pDXA as well as quantitative 
ultrasound (QUS) are clinically the most relevant imaging modalities at the moment. Bone 
imaging modalities can be used to diagnose reliably osteoporosis, to estimate the fracture 
risk and to monitor the response to the therapeutic interventions (Cummings, Bates & Black 
2002). However, in estimating an individual’s fracture risk, DXA should be utilized in 
concordance with clinical risk factors such as the fracture risk assessment tool (FRAX) 
(Kanis et al. 2010). 
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2.2.2 Dual-energy X-ray absorptiometry (DXA) 
DXA is considered as the golden standard for densitometry. Central DXA is used to 
measure BMD in hip (total, femoral neck, Ward’s triangle and trochanter), AP and lateral 
spine as well as total body BMD. Femoral and lateral spine BMD explains about 70% of a 
bone’s capability to resist fracture (Perilli et al. 2012). BMD varies between different sites 
around the body and there is only a moderate inter-correlation between BMD at different 
sites (Melton et al. 2005). Thus, BMD at a specific site is the best predictor of the fracture 
risk at that particular site (Melton et al. 2005). DXA applies two different peak X-ray 
energies, which are used to distinguish both mineralized (hydroxyapatite) bone and soft 
tissue (Isales, McDonald 2007). In terms of physical interactions at a lower energy (~ 40 kV) 
the photoelectric effect and Compton scattering (~80kV) predominate in both tissues (Blake, 
Fogelman 2010). Compared to the older generations of pencil-beam DXA-densitometers 
(e.g., DPX and DPX-IQ), newer narrow-angle fan-beam (e.g., Prodigy) and cone beam 
machinery have reduced scanning times and improved the image quality (higher spatial 
resolution), however, at the cost of requiring exposure of the subject to an increased 
radiation dose (Blake, Knapp & Fogelman 2005). 
pDXA devices are used to measure the BMD in heel, wrist or fingers. By using the same 
WHO T-score criteria for osteoporosis as with central DXA, the risk of osteoporosis would 
be underestimated (Fordham, Chinn & Kumar 2000). The National Osteoporosis Society 
recommends T-score thresholds, which are specific for each type of peripheral device. This 
approach identifies osteoporotic patients with 90% sensitivity and 90% specificity 
compared to central DXA (Blake et al. 2005). According to the ISCD pharmacological 
therapy may be started based on pDXA results however the validity for monitoring 
treatment efficacy has not been demonstrated (Hans et al. 2008b). The Current Care 
guideline of the Finnish Medical Society Duodecim recommends that pDXA devices may 
be used as a screening test for osteoporosis in individuals at an increased risk for 
osteoporosis (Välimäki et al. 2006). The Current Care guideline task force group 
recommends that some of the patients with normal pDXA results should undergo central 
DXA measurement because false negative results may occur using pDXA devices (i.e. 
normal BMD with pDXA compared to low BMD with central DXA). Furthermore, task 
force group recommends that patients with low BMD using pDXA are guided to central 
DXA measurements. However, pharmacological treatment for osteoporosis may be started 
based on pDXA measurements, if it is not possible to confirm the results adopted with 
pDXA devices (Välimäki et al. 2006). 
2.2.3 Quantitative ultrasound (QUS) 
QUS instrumentation typically measures both the speed of ultrasound (SOS, m/s or 
ultrasonic wave propagating velocity) and broadband ultrasound attenuation (BUA, 
dB/MHz, attenuation/frequency). SOS is influenced not only by the elasticity of bone but 
also by its density. The high attenuation of sound in BUA measurements of cancellous bone 
in heel is due to diffraction, scattering and absorption of sound waves by the large number 
of trabeculae, bone marrow and soft tissue (Malavolta, Mule & Frigato 2004, Langton, Njeh 
2008). Thus, BUA can reflect porosity, connectivity and trabecular thickness (Malavolta, 
Mule et al. 2004) and thus it can provide information about bone quality in terms of bone 
architecture and its elasticity (Glüer 2008). 
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The heel compromises 90-95% of trabecular bone and exhibits a similar age-dependent 
bone loss pattern to that occurring in the spine of women (Magkos et al. 2004). According to 
ISCD, the heel is the recommended ROI for making QUS measurements (Krieg et al. 2008). 
ISCD recommends that if central DXA is not available, and then pharmalogical treatment 
may be initiated based on the QUS measurements in conjunction with recognized clinical 
risk factors. However, QUS may not be used to monitor the effects of pharmalogical 
treatment (Krieg et al. 2008) but further research is needed to confirm whether QUS can 
reliably monitor the efficacy of treatment (Gonnelli, Caffarelli & Nuti 2007). The Current 
Care guideline of the Finnish Medical Society Duodecim recommends that QUS devices 
cannot replace central DXA equipment (Välimäki et al. 2006). Caution is also necessary 
because of the false negative results associated with QUS measurements compared to 
central DXA devices (Välimäki et al. 2006). The diagnostic osteoporosis thresholds for QUS 
and pDXA measurement differ from the central DXA WHO criteria (Clowes, Peel & Eastell 
2006). Unfortunately, one encounters significant intra- and intermanufacturer variation in 
the values produced by different QUS devices (Krieg et al. 2003). As the availability of 
central DXA equipment is limited, portable devices, such as QUS, may be considered as 
relatively low cost screening tools for bone mass (Marin, Lopez-Bastida et al. 2004). Unlike 
the more established central DXA, QUS requires no ionizing radiation, is cheaper, takes up 
less space and is easier to use than densitometry-based equipment (Krieg et al. 2008). In 
comparison to central DXA-measurements, the risk of false positive (sensitivity) and false 
negative (specificity) results with QUS is around 7-21% and 10-72%, respectively (Krieg et 
al. 2008, Floter et al. 2011). Further, other QUS parameters, stiffness index (Achilles, Lunar) 
and the quantitative ultrasound index (Sahara, Hologic) are calculated as 0.28 x SOS + 0.67 x 
BUA – 420 and 0.41 x SOS + 0.41 x BUA – 571, respectively (Hartl et al. 2002). 
As both QUS and DXA predict independently future fragility fractures, neither of the 
techniques should be preferred over the other (Krieg et al. 2008). The relative risk of hip 
fracture for 1 SD decrease of heel BUA, SOS, stiffness index and quantitative ultrasound 
index is 1.7, 2.0, 2.3 and 2.0, respectively (Moayyeri et al. 2012). Heel QUS and DXA-
assessed (central) BMD appear to be rather equally predictive for future fracture risk 
(Marin et al. 2006). Validated QUS devices from different manufacturers predict fracture 
risks with similar performances (Moayyeri et al. 2012). This suggests that an effective 
screening and fracture risk assessment with portable equipment could be a realistic option 
(Hans et al. 2008a, Navarro Mdel et al. 2012). 
2.3 OBESITY 
2.3.1 Definition of obesity 
According to WHO, obesity is a medical condition in which excess body fat has 
accumulated to such an extent that it may exert an adverse effect on health (WHO 2000). 
Obesity is commonly defined by body mass index (BMI, kg/m2) (Table 1.) (WHO 1995, 
WHO 2000). One-third of adult women in the United States were obese between the years 
2009-2010 according to NHANES (Flegal et al. 2012). Several cardiovascular risk factors as 
well as further measurement of anthropometry such as waist circumference or waist-to-hip 
ratio (WHR) are important when assessing an obese patient in clinical medical practice 
(Haslam, James 2005). Furthermore, obesity is associated with severe morbidity such as 
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type 2 diabetes, hypertension, dyslipidemia, stroke, coronary heart disease, obstructive 
sleep apnea, certain types of cancer, degenerative joint disease, non-alcoholic fatty liver 
disease, reflux esophagitis, venous stasis ulcers, cholelithiasis, erectile dysfunction and 
polycystic ovary syndrome (Haslam, James 2005, Forte et al. 2012). Finally, obesity is one of 
the leading preventable causes of premature death (Hjellvik et al. 2013). Therefore, in 
overweight or obese individuals, a weight reduction of 10% or more is recommended since 
this can achieve a significant reduction in co-morbid risk factors (Barte et al. 2010). 
 
Table 1. Categorisation of BMI. 
 
BMI category BMI kg/m2 
Severely underweight <16.5 
Underweight 16.5-18.4 
Normal 18.5-24.9 
Overweight 25-29 
Obesity (Class 1) 30-34 
Severe obesity (Class 2) 35-39 
Morbid obesity (Class 3) 40-49 
Super obesity (Class 4) >50 
 
2.3.2 Measurement of obesity 
There are several methods available for estimating obesity in addition to the traditional 
anthropometric tape and scale measurements. However, in elderly people, the weakness of 
BMI is that it does not properly take into account of the height loss, LBM loss and 
accumulation of visceral adipose tissue (VAT) (Han, Tajar & Lean 2011). BMI and waist 
circumference may be an inaccurate measure of percentage body fat in an individual, 
although they do correlate fairly well with DXA-measured percentage body fat in groups of 
subjects. BMI is the best surrogate measurement of DXA-measured adiposity in women 
(Flegal et al. 2009). Anthropometric studies are often clinically used as indirect 
measurements of VAT. WHR, waist circumference and skinfold thickness measurements 
are often used to further evaluate obesity and the risk of cardiovascular diseases. Of course 
these indirect measurements cannot separate VAT and subcutaneous adipose tissue (SAT), 
but especially WHR and waist circumference are more strongly correlated with VAT than 
with SAT and therefore these measurements can be used as surrogates for VAT (Gradmark 
et al. 2010). However, some have found that waist circumference and BMI correlate better 
with FM and SAT than with VAT (Camhi et al. 2011). 
MRI and CT can be considered as reference methods for quantitative measurement of 
appendicular skeletal muscle as well as VAT and SAT (Meng, Lee & Saremi 2010). These 
methods, however, are only used in scientific research and are not generally used for 
clinical measurements due to their cost and poor availability. The radiation dose of CT 
scans also limits its widespread use (Mancini, Ferrandino 2010). DXA can measure both 
regional (head, trunk, arms and legs) and overall body composition parameters and thus 
can separate lean body mass (LBM), fat mass (FM) and BMD from each other accurately, 
precisely and with a minimal radiation dose (Toombs et al. 2012). The DXA measured 
standard trunk or manually selected abdominal fat correlate well with VAT and show 
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minimal between- and within-examiner variation (Clasey et al. 1999, Kamel, McNeill & Van 
Wijk 2000). 
DXA assumes that there are three compartments (fat, lean and bone mass), whereas the 
4-compartment model further separates lean tissue into water and protein (Toombs et al. 
2012). As compared to the 4-compartment model, DXA seems to underestimate FM% in 
lean subjects and overestimate it in the obese (Toombs et al. 2012). The disagreement of 
DXA with the 4-compartment model ranges from 5% underestimation to 3% overestimation 
of adiposity (Toombs et al. 2012). For example, Hologic QDR 4500A overestimated and 
underestimated LBM and FM by 5%, respectively (Schoeller et al. 2005). Body composition 
measurements with different DXA densitometers are sometimes in perfect agreement with 
each other, whereas occasionally up to 5 kg mean differences in FM or LBM have been 
reported between different devices (Toombs et al. 2012). 
DXA is a reliable method for measuring abdominal fat (Glickman et al. 2004). When 
compared to CT, DXA is also a good alternative for measuring abdominal fat in the elderly 
(Snijder et al. 2002). The correlation between CT and DXA-measured overall abdominal fat 
is relatively good (r = 0.8-0.9) but somewhat lower for predicting VAT(r=0.6-0.7) (Snijder et 
al. 2002). There is controversy regarding measurement of abdominal FM by DXA and CT 
devices. Snijder et al. reported that compared to CT, pencil beam DXA (Hologic QDR 1500) 
underestimates total abdominal fat by about 10% with the underestimation being more 
apparent in individuals with less abdominal fat (Snijder et al. 2002). In contrast, Bredella et 
al. reported that compared to CT, fan beam DXA (Hologic Discovery A) overestimates total 
abdominal fat by 58% in anorectic subjects and by 26% in overweight or obese subjects 
(Bredella et al. 2013). Thus, compared to values obtained with CT, the measurement of total 
abdominal fat with DXA devices seems to be less reliable especially in anorectic patients, 
whereas the difference between DXA and CT measured abdominal fat decreases with 
increasing adiposity (Snijder et al. 2002, Bredella et al. 2013). In comparison with CT, DXA 
was reported to underestimate trunk and thigh fat and to overestimate thigh muscle mass 
and this error increased with increasing body weight (Bredella et al. 2010). Some 
investigators have proposed that DXA is not superior to waist circumference and BMI 
when measuring VAT and SAT (r = 0.6-0.8 compared to CT) (Gradmark et al. 2010). 
Furthermore, when compared to CT measurements, the values of changes in DXA-
measured abdominal fat correlated better with SAT (r = 0.9) than VAT (r= 0.7) after weight 
loss compared to CT measurements (Doyon et al. 2011). The validity of DXA measured 
trunk-leg fat ratio for measuring VAT has not been confirmed (Zillikens et al. 2010). 
Older DXA technology cannot differentiate directly between VAT and SAT. However, 
GE Healthcare Lunar iDXA and Prodigy as well as Hologic Discovery A fan beam 
densitometers are able to quantify the amount of VAT using either the CoreScan (GE) 
application of the enCORE software version 14 or the InnerCore (Hologic) application, 
respectively (Kaul et al. 2012, Ergun et al. 2013, Bredella et al. 2013). It has been claimed that 
DXA seems to be a reliable method for estimating VAT (Micklesfield et al. 2012). However, 
controversy exists over the accuracy of DXA scanners’ abilities to measure VAT. As 
compared to a CT scan, iDXA overestimates VAT by only 56 cm3 or 5.9% while the average 
amount of VAT was 1 kg (Kaul et al. 2012). In addition, the correlation (r2) between waist 
circumference and CT measured VAT was much lower (r2 = 0.69), as compared to the 
correlation between VAT measured with iDXA or CT (r2 = 0.96) (Kaul et al. 2012). Bredella 
et al. reported that when compared to CT, fan beam DXA (Hologic Discovery A) 
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overestimates VAT by 47% in anorectic subjects and by 18% in overweight and obese 
subjects (Bredella et al. 2013). Furthermore, compared to CT, DXA overestimates SAT by 
61% in anorectic subjects and by 17% in overweight or obese subjects (Bredella et al. 2013). 
Thus, measurement of abdominal and VAT by DXA devices seems to be more reliable in 
overweight subjects than in thin subjects. In addition, the accuracy of a DXA scanner to 
measure different abdominal fat compartments may depend on the individual commercial 
DXA device.  
2.3.3 Pathophysiology of obesity 
Every aspect of metabolism is under genetic control (Roth, Szulc & Danoff 2011). However, 
a changing modern environment and lifestyle may override the physiological controls of 
appetite and homeostatic body-weight regulation (Lenard, Berthoud 2008). Thus, from an 
evolutionary perspective, human reproduction, immunity and having a constant 
temperature are processes which require much energy. Gynoid fat depositions are less 
lipolytic as compared to VAT and are meant to be mobilized during times of pregnancy 
and nursing (Lev-Ran 2001). Previously, fat deposits were important in managing the wide 
seasonal fluctuations in energy supply and demand (e.g. in hunter-gatherer societies). 
Higher caloric intake and low energy expenditure lead inevitably to weight gain. 
However, the regulation of weight occurs in a more complex manner. In the short term, 
hunger and an empty stomach (ghrelin from stomach and pancreas) will increase food 
intake. Conversely, the presence of food in the gastrointestinal tract cause the release of 
cholecystokinin, glucagon like peptide-1 (GLP-1) and peptide YY signal short-term satiety. 
Adiponectin and leptin (its amounts being proportional to adipose tissue) and insulin 
(metabolism) signal long-term satiety. On the other hand, obesity is characterized by 
hyperinsulinemia, insulin resistance and leptin resistance. Thus, hyperinsulinemia also 
decreases dopamine clearance e.g. its uptake in the hedonic pathway, which elevates the 
increase in the reward due to food and this can cause increased food intake and it maintains 
hyperinsulinemic state in the long-term, insulin functions as an endogenous leptin 
antagonist (Kamiji, Inui 2007). In women, testosterone and progesterone stimulate appetite, 
whereas estradiol inhibits food intake through hypothalamic relays and by interacting with 
gut hormones (Hirschberg 2012). The stimulation of endocannabinoid receptors enhances 
food intake and sensations of hunger (Di Marzo, Ligresti & Cristino 2009). Finally, these 
peripheral afferent signals of satiety and hunger are mediated through the brainstem to the 
hunger and satiety centers in the hypothalamus (Kamiji, Inui 2007). This complex 
communication between hormones, hypothalamic centers, cortex, brainstem, pituitary 
gland and mesolimbic reward system regulates hormonal neuroendocrine functions, caloric 
intake and energy expenditure.  
2.4 ADIPOSITY, BMD AND FRACTURES 
2.4.1 Adiposity and BMD 
Body weight is one of the principal determinants of BMD with a typical correlation ranging 
from 0.3 to 0.6 (Reid 2010). In contrast, the association between BMI and BMD is slightly 
lower compared to the association between body composition parameters and BMD 
(Akdeniz et al. 2009, Sheng et al. 2011), although there have been opposite findings have 
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been expressed (Leslie 2009). However, compared to BMI or body weight, the relationship 
between BMD and resting energy expenditure (i.e. in women 655 + (9.56 x body weight) + 
1.85 x body weight) – 4.68 x age)) maybe even stronger (Afghani, Barrett-Connor 2009). 
Postmenopausal women have 1.5 and 3 times higher spinal BMD from an incremental body 
weight increase as compared to premenopausal women and men, respectively (Puntus et 
al. 2011). For example, in the European vertebral osteoporosis study of 19 European 
countries, body weight explained 11.5%, 12.0% and 16.6% of the variance in the spinal, 
femoral neck and trochanter BMD values, respectively (Lunt et al. 2001). When compared 
to lean people, obese individuals have about a 20% higher total bone mineral content 
(BMC) (Cifuentes et al. 2003). In general, a BMI of 30 kg/m2 is associated with BMD values 
which are 8-10% greater in lumbar spine and 9-12% greater in hip as compared to an 
individual with a BMI of 20 kg/m2 (Bjarnason, Christiansen 2000, Mendez et al. 2012). In 
addition, the BMD of the non-weight-bearing wrist is associated positively with overweight 
(Forsmo et al. 2006). Heavier body weight is positively associated with bone strength 
parameters also in other non-weight bearing bones (Lorbergs et al. 2011). The odds ratio 
(adjusted for medications, age and health status) for having spinal or femoral neck 
osteoporosis was 1.8 (BMI <19 kg/m2), 0.5 (25-30 kg/m2) and 0.3 (≥30 kg/m2). Thus, the risk 
of osteoporosis decreased by 12% for every unit increase in BMI (Asomaning et al. 2006). 
Table 2 shows typical associations between anthropometry and bone densities. 
Osteoporosis of the lumbar spine (L2-L4) was diagnosed in 37.5%, 23.1% and 14.1% Dutch 
women (mean age 63, SD 7) with a BMI values of less than 24, 24-30 and over 30 kg/m2, 
respectively (van der Voort, Geusens & Dinant 2001). The odds ratio for having spinal 
osteoporosis was 3.1 (age<60) and 0.8 (age≥60) in women with a BMI of 27 kg/m2 or less, 
whereas women with a BMI of over 27 kg/m2 were less likely to suffer osteoporosis (0.3, 
age<60 and 0.6 age≥60) (van der Voort et al. 2000). According to NHANES III, 33% of 
women over the age of 50 years with a BMI <25 kg/m2 were osteoporotic compared to only 
11% with BMI ≥25 kg/m2 (Looker, Flegal & Melton 2007). For example in women over 51 
years of age, it is possible to predict mean femoral neck T-score as follows: T-score = -1.332 - 
0.0404 x (age) + 0.0386 x (body weight) (Wildner et al. 2003). Ethnic and genetic factors can 
modify the associations between body composition, obesity and BMD (Aloia et al. 1999, 
Castro et al. 2005, Wallace et al. 2005). According to NHANES III, white women with a BMI 
of over 25 kg/m2 had 13.9% higher BMD compared to women with a BMI of less than 25 
kg/m2, whereas  the difference was 14.5% and 19.7% with Mexican and black women, 
respectively (Looker, Flegal & Melton 2007). The risk of osteoporosis is greatest in 
underweight women. According to EPIDOS, 21.9% of women in the lowest weight centile 
(mean body weight 43.4 kg) were osteopenic, 45.9% had T-scores from -3.5 to -2.5 and 30.6% 
had femoral neck T-score below -3.5, respectively. In contrast, the respective percentages 
were 57.6%, 19.4% and 1.4% in the highest body weight centile (mean 80.1 kg) and 48.5%, 
41.5% and 5.2% in the 40-50th centile (mean 57.5 kg) (Dargent-Molina et al. 2000). Thus, the 
odds ratio for having femoral neck T-score ≤ -3.5 in the EPIDOS study showed body weight 
dependency i.e. 13.3 (<52.5 kg), 5.7 (52.5-59 kg) and 2.9 (59-66 kg), respectively (Dargent-
Molina et al. 2000). Lower body weight has been associated with a greater bone loss 
compared to women with higher body weight (Hannan et al. 2000, Macdonald et al. 2005). 
Figure 2 shows the percentages of low T-score values according to age and anthropometry. 
In contrast, obesity has been associated with an increased risk of osteoporosis according to 
one small study (Greco et al. 2010). Finally body size, bone size and bone mineral values are 
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closely interrelated and this both affects and complicates the interpretation of the results 
(Reid 2010). 
 
Table 2. Anthropometry and bone density in selected studies from the 21st century. Statistically  
significant difference between BMI or weight groups (p-value):  ** p ≤ 0.01, *** p ≤ 0.001. 
 
Author Publ. year 
Country 
BMI 
(kg/m2) 
or weight 
(kg) 
n Age (years) 
mean (SD) 
Years since 
menopause 
mean (SD) 
Lumbar spine  
BMD (g/cm2) 
or T-score 
Femoral neck 
BMD (g/cm2) 
or T-score 
1. Mendez 2012 
Mexico 
20-24.9 
25-29.9 
30-34.9 
35-39.9 
>40 
123 
318 
211 
96 
65 
59.6 (7.5) 
60.4 (7.8) 
60.2 (7.1) 
59.1 (6.9) 
58.5 (6.1) 
10.7 (8.2) 
12.0 (8.5) 
12.3 (8.2) 
10.9 (8.8) 
11.1 (7.9) 
0.80** 
0.84 
0.87 
0.91 
0.95 
0.69** 
0.73 
0.77 
0.79 
0.80 
2. Bjarnarson 2000 
Denmark 
<23.48 
23.48-
26.75 
>26.75 
51 
51 
51 
52.8 (2.4) 
54.1 (2.9) 
53.5 (3.4) 
 
3.3 (2.3) 
3.2 (1.7) 
3.3 (1.5) 
0.916** 
0.961 
1.009 
0.706*** 
0.741 
0.776 
3. Looker 2007 
USA 
NHANES 3 
<25 
≥25 
 
1254 
2045 
50-80+ 
 
  0.624*** 
0.720 
 
4. Akdeniz 2009 
Turkey 
25.9/62.7 
27.3/68.1 
30.5/77.8 
 
66 
193 
281 
66.5 (9.9)*** 
61.2 (8.6) 
56.4 (6.4) 
=59.3 (8.5) 
18.9 (9.5)*** 
14.1 (8.6) 
8.51 (6.4) 
=11.8 (8.5) 
-3.6*** 
-2.6 
-1.2 
 
-2.9*** 
-1.6 
0.17 
 
 
1. (Mendez et al. 2012), 2. (Bjarnason, Christiansen 2000), 3. (Looker, Flegal & Melton 2007), 
4. (Akdeniz et al. 2009). 
 
There are several osteoporosis risk-assessment instruments that take into account body 
weight as a major risk factor. Some of these instruments identify women with low BMD 
from moderate to well (area under curve, AUC, 0.70-0.89) (Table 3). However, sometimes 
these instruments function only poorly or even fail to detect osteoporotic individuals from 
the healthy population (AUC, 0.13-0.66) (Nelson et al. 2010a) (Table 3): 
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Table 3. Osteoporosis risk-assessment instruments and selection cut-points for referral to densitometry. 
 
Instrument or 
study 
Studies, 
n 
Participants, 
n 
Range 
of AUC 
Risk factors (points) Selection cut-
point: 
recommendation 
for densitometry 
1. ABONE 
Age, BOdy size, 
No Estrogen 
1 2365 0.72 Weight < 63.5 kg (1) 
Age > 65 yrs. (1) 
Never estrogen (1) 
≥ 2 
2. Body weight 6 9065 0.13-
0.79 
Weight < 70 kg  
3. EPIDOS 
EPIDemiologie 
de 
l'OStéoporose 
(weight only) 
1 6958 0.74 Weight < 59 kg  
4. ModAMS 
Modified 
AMSterdam 
1 287  Weight < 60 kg (1) 
Any previous steroid use 
(1) 
Immobility (1) 
Age > 50 yrs. (1) 
Rheumatoid arthritis 
activity (1) 
≥ 3 
5. MOI 
Mikkeli 
Osteoporosis 
Index 
1 300 0.66-
0.72 
Weight ≤ 57 kg (4) 
               58-63 kg (3) 
               64-70 kg (2) 
               71-79 kg (1) 
Age ≥ 75 yrs. (6) 
        70-74 yrs. (4) 
        65-69 yrs. (3) 
        60-64 yrs. (2) 
        55-59 yrs. (1) 
Fracture (2) 
Family history of hip 
fracture or spinal 
osteoporosis (2) 
Smoking (2) 
Shortening of the stature:   
        3-4 cm (1) 
        5 cm (2)                    
Use of arms to rise from a 
chair (2) 
≥ 2 
6. NOF 
National 
Osteoporosis 
Foundation 
3 3092 0.60-
0.70 
Weight < 57.6 kg (1) 
Age ≥ 65 yrs. (1) 
Minimal trauma fracture 
after the age of 40 yrs. 
(1) 
Family history of fracture 
(1) 
Current smoking (1) 
≥ 1 
7. OPERA 
Osteoporosis 
Prescreening 
Risk 
Assessment 
1 1522 0.81 
(Femoral 
neck) 
0.87 
(Lumbar 
spine) 
Weight < 57 kg (1) 
Age ≥ 65 yrs. (1) 
Early menopause < 45 
yrs. (1) 
Low trauma fracture after 
the age of 45 yrs. (1) 
Steroid use > 6 months > 
5 mg/day (1) 
≥ 2 
8. ORAI 10 11093 0.32- Weight < 60 kg (9) ≥ 9 
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Osteoporosis 
Risk 
Assessment 
Instrument 
0.84                60.0-69.9 kg 
(3) 
Age ≥ 75 yrs. (15) 
        65-74 yrs. (9) 
        55-64 yrs. (5) 
Currently no estrogen (2) 
9. OSIRIS 
Osteoporosis 
Index of Risk 
5 2657 0.63-
0.80 
+0.2 x Weight (kg) 
-0.2 x Age (yrs.) 
History of low impact 
fracture (-2) 
Estrogen therapy (+2) 
Risk: 
< -3 high 
-3 to +1 medium 
> +1 low 
10. OST 
Osteoporosis 
Self-
assessment 
Tool 
10 13825 0.33-
0.89 
0.2 x (Weight (kg) - Age 
(yrs.)) 
< 2 
11. SCORE 
Simple 
Calculated 
Osteoporosis 
Risk Estimation 
9 13710 0.66-
0.87 
(-1 x weight pounds) / 
10 
e.g. Pounds = 2.2 x kg 
Age (yrs.) 3 x first digit 
History of minimal fracture 
after the age of 45 years 
(4/fracture, max. 12) 
Race non-black (5) 
Rheumatoid arthritis (4) 
Never user of estrogen (1) 
≥ 6 
12. SOFSURF 
Study of 
Osteoporosis 
Fractures —
Study Utilizing 
Risk Factors 
1 208 0.72 Weight < 59 kg (2) 
               < 68 kg (1) 
(Age (yrs.) - 65) x 0.2 
Current smoker (1) 
History of postmenopausal 
fracture (1) 
≥ 1 
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Figure 2. Percentage of subjects with low T-score values according to BMI, body weight or age. A) Femoral neck T-score ≤ -
3.5 vs. body weight, EPIDOS, 2000, France, n=4638, over 75 years of age (Dargent-Molina et al. 2000). B) T-score ≤ -2.5 vs. 
BMI, Manitoba, 2009, Canada, n=8254, age 52.7 (SD 4.9) (Morin, Tsang & Leslie 2009). C) Femoral neck T-score ≤ -2.5 vs. 
BMI and age, NHANES III, 2007, USA, n=1877, over 50 years of age (Looker, Flegal & Melton 2007). D) T-score ≤ -2 vs. age, 
fracture occurrence (Fx+/Fx-) and weight, Dubbo, 2004, Australia, n=846, age 70.6 (SD 7.3), Fx +=Prior fragility fracture 
(Nguyen et al. 2004). 
2.4.2 Body composition and BMD 
In premenopausal and perimenopausal women, the bones adapt to prevalent muscle loads 
and LBM is believed to be the main determinant of BMD values (Wang et al. 2005, Zagarins 
et al. 2010). Thus, both ground-impact forces (gravitational loading, e.g. running) and 
muscle contractions (i.e. muscle loading, e.g. weight lifting) may improve cortical thickness, 
bone metabolism and reduce fracture risk (Kohrt, Barry & Schwartz 2009). There is still 
some controversy concerning which one of the two DXA measured body composition 
parameters (FM or LBM) is better related to BMD in postmenopausal women. Some studies 
have indicated that FM is more important (Marques et al. 2012, Nur et al. 2013), whereas 
some claim that both LBM and FM are positively associated with BMD values (Rikkonen et 
al. 2012, Zhang et al. 2012). In sedentary women, FM and LBM were associated with BMD, 
whereas in exercising women, only LBM could be linked with higher BMD values (Douchi 
et al. 2003). A hip structure analysis revealed that femur BMD and indices of bone 
geometry: axial (cross-sectional area) and bending strength (section modulus) were higher 
in women with higher BMI, but they were proportional to LBM but not to FM (Beck et al. 
2009). 
In contrast, some studies have observed that increasing adiposity is deleterious for 
bones. Interestingly, the initial positive association between FM and BMD changed into an 
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inverse association between FM and BMD after adjustment for body weight (Hsu et al. 
2006). Trunk FM was inversely related to BMD values in a multiethnic cohort of women, 
however they reported only multivariate results (adjusted for body weight) (Lu et al. 2011). 
Thus, it has been reported that multicollinearity between FM, LBM and body weight may 
lead to false conclusions about the association between soft tissues and BMD (Reid 2010). 
The recent meta-analysis conducted by Ho-Pham et al. suggests that of the body 
composition parameters (FM and LBM) LBM is the main determinant of femoral neck and 
lumbar spine BMD values in both genders, although both body composition parameters are 
associated with BMD values (Ho-Pham, Nguyen & Nguyen 2014). Especially in men LBM 
is associated with femoral neck (r=0.43) and lumbar spine (r=0.36) BMD values, whereas FM 
is less important with respect to femoral neck (r=0.18) and lumbar spine (r=0.23) BMD 
values. Similarly, in premenopausal women, the association between LBM and femoral 
neck (r=0.45) and lumbar spine (r=0.31) BMD values is stronger than the association 
between FM and femoral neck (r=0.30) and lumbar spine (r=0.19) BMD values. Only in 
postmenopausal women FM is as important as LBM to femoral neck (e.g. LBM, r=0.33 and 
FM, r=0.31) and lumbar spine (e.g. LBM, r=0.34 and FM, r=0.31) BMD values. However, 
individual studies in the meta-analysis showed also contradictory results and the effect of 
FM and LBM on BMD values varied from slightly negative to strong positive correlations. 
Thus, these heterogenous results in the meta-analysis may be explained by different study 
designs with variabilities in age groups, gender, sample sizes and ethnicities (Ho-Pham, 
Nguyen & Nguyen 2014). 
2.4.3 Central obesity, bone marrow fat and BMD 
The association between body fat distribution and postmenopausal central BMD has not 
been as extensively investigated, as the association between BMI or body weight and BMD. 
In one study conducted in postmenopausal women, the DXA-measured abdominal FM was 
positively correlated with total body BMD measurements (Warming, Ravn & Christiansen 
2003). Trunk FM was the main determinant of postmenopausal right leg BMD (Kawamura 
et al. 2011). Trunk FM was positively associated with total body BMD in postmenopausal 
women, whereas LBM was the main determinant of premenopausal BMD in Oriental 
women (Kuwahata et al. 2008). A waist circumference of over 80 cm was positively 
associated with spinal and femoral neck BMD values in postmenopausal women (Dytfeld 
et al. 2011). The total abdominal FM as measured by MRI was positively associated with 
spinal but not with hip BMD in postmenopausal women (Stewart et al. 2002). The WHR has 
been found to be positively associated with femoral neck BMD in measurements conducted 
with the older generation pencil beam (Lunar DPX) equipment in postmenopausal women 
(Heiss et al. 1995). DXA-measured (Prodigy) trunk-leg fat ratio was associated with a 
higher spinal BMD, but not with femoral neck BMD (Zillikens et al. 2010). Thus, the 
redistribution of fat tissue does seem to affect BMD. However, the positive associations 
between android fat distribution and BMD are largely explained by higher BMI or body 
weight (Zillikens et al. 2010). 
Some studies have not detected any relationship between abdominal fat and BMD 
values. DXA-measured upper body fat distribution was not associated with hip BMD 
(Kirchengast et al. 2001). The initial positive association between WHR and total body and 
hip BMD was no longer apparent after adjustment for FM and LBM (Jurimae et al. 2008). 
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Many studies have concluded that adiposity and VAT have negative influences on 
postmenopausal BMD. The initial positive association between FM and spinal BMD turned 
into a negative association after adjustment for body weight in Korean women either under 
or over 50 years of age, even though WHR was consistently inversely associated with spinal 
BMD values (Kim et al. 2009). Abdominal and total FM was inversely associated with hip 
and spinal BMD after adjustment for body weight in Puerto Rican women, however only 
multivariate results were shown (Bhupathiraju et al. 2011). The DXA-measured android to 
gynoid FM ratio was not associated with premenopausal BMD values or postmenopausal 
BMD values after adjustment for FM. However, after adjustment for FM and LBM, the 
DXA-measured android to gynoid FM ratio was inversely associated with total body BMD 
in Chinese women (Fu et al. 2010). However, the inclusion of abdominal fat and 
anthropometrical parameters (e.g. body weight, BMI, FM) into the same model can result in 
multicollinearity, which may explain the negative association between abdominal fat and 
BMD values (Reid 2010). 
In younger women, SAT is beneficial for bone structure and strength, whereas VAT and 
bone marrow fat have detrimental effects on the skeleton in both the general population 
and in anorexic subjects (Bredella et al. 2013, Fazeli et al. 2013). However, the trunk-leg fat 
ratio as measured by DXA has been positively associated with spinal BMD in 
premenopausal women of Oriental origin (Douchi et al. 2000a). VAT measured by CT and 
bone marrow fat measured by magnetic resonance spectroscopy (MRS) have been shown to 
have negative effects on bone (Sheu, Cauley 2011). The amount of bone marrow fat may be 
also associated with fragility fractures (Patsch et al. 2013). However, the association 
between CT-measured VAT and BMD in postmenopausal women is less clear because 
some investigators have included both pre- and postmenopausal Asian women in their 
study populations (Choi et al. 2010). In addition the multicollinearity between VAT, body 
weight and BMD may partly contribute to the above inverse relationship between VAT and 
BMD in Asian women (Yamaguchi et al. 2009, Reid 2010). Race also markedly modifies the 
body fat distribution as well as the relationship of anthropometry with BMD and thus these 
results on Asian women cannot be extrapolated to Caucasian women (Nazare et al. 2012). 
Thus it seems that adiposity has associations with bone that are age-, gender-, menopausal 
status-, adipose depot-, and bone compartment-specific (Ng et al. 2013). 
2.4.4 Weight changes and BMD 
In general, weight gain leads to less bone loss (Park et al. 2007), whereas intentional or un-
intentional weight loss are associated with lower BMD values and enhanced bone loss 
(Macdonald, New et al. 2005). A dietary-induced weight reduction of 10% has been said to 
increase bone loss by 1-4% as compared to the situation in individuals with stable weight 
(Shapses, Sukumar 2012). In one study, a 10 kilogram weight loss was associated with a 4% 
BMD loss in the non-weight-bearing distal forearm (Wilsgaard et al. 2009). In 
postmenopausal women, BMD loss during weight loss does not seem to fully recover with 
weight regain (Villalon et al. 2011, Von Thun et al. 2013). However, there is a report that in 
some women BMD may remain unaffected during weight gain (Hannan, Felson et al. 2000). 
Some previous studies have also found discrepancies between the magnitude of the 
changes in BMD and BMC when large weight changes occur (Fogelholm, Sievanen et al. 
2001). Extreme weight loss due to dieting or surgical intervention has resulted in more 
extreme bone loss (Coates, Fernstrom et al. 2004). After a Roux-en-Y gastric bypass (both 
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malabsorptive and restrictive procedure) for morbid obesity, a significant weight loss 
occurs but there may also be malabsorption of calcium and vitamin D, resulting in 
increased bone turnover (Fleischer, Stein et al. 2008). In addition, gastric banding 
(restrictive procedure) not only induces weight loss but also exerts negative bone 
remodeling effects (Giusti, Gasteyger et al. 2005). It has been claimed that there is a greater 
bone loss (>1%) with weight loss in normal-weight subjects compared with overweight or 
obese individuals (<1% bone loss) (Nguyen, Sambrook & Eisman 1998). Finally, the BMD 
response to weight loss may differ significantly between instruments from different 
manufacturers (Tothill 2005). 
2.4.5 Mechanisms of biological association between adiposity and bone tissue 
There are several biological factors that explain the apparently positive and negative 
associations between bone and adipose tissue. Osteocytes are thought to sense mechanical 
loading of the skeleton and this may account for some of the positive association between 
body weight and BMD (Greene et al. 2012). In postmenopausal women, aromatization of 
androgens into estrogens (the aromatization of androstenedione and testosterone to estrone 
and estradiol, respectively) occurs in both peripheral lean (25-30%) and fat tissue (10-15%) 
(Douchi, Yamamoto et al. 2000). Estradiol, testosterone, lutenizing hormone levels, follicle 
stimulating hormone and sex hormone-binding globulin levels are positively associated 
with increasing body weight (Stolzenberg-Solomon et al. 2012). Viscerally obese 
postmenopausal women exhibit a more androgenic hormone profile (Janssen et al. 2010). In 
overweight and obese postmenopausal women, the testosterone level was associated with 
lumbar spine BMD, whereas levels of both estradiol and testosterone were associated with 
femoral neck BMD (Filip, Raszewski 2009). 
Obesity is associated with reduced plasma levels of both 1,25- and 25-
hydroxycholecalciferol due to its deposition in adipose tissue (Vimaleswaran et al. 2013). 
Vitamin D deficiency and elevated PTH levels were encountered in 64% and 14% of 
morbidly obese patients, respectively (DiGiorgi et al. 2008). PTH levels may be suppressed 
at lower vitamin D levels in obese subjects compared to leaner people (Shapses et al. 2013a). 
Malabsorptive procedures, but not gastric banding, for morbid obesity have been 
associated with impairment of calcium absorption and vitamin deficiency, which in turn 
can cause secondary parathyroidism and thus increased production of vitamin D and 
release of calcium from bones (Toelle et al. 2012). Dieting also reduces the total amount of 
calcium absorbed from the diet (Shapses et al. 2013b). There is a report that serum PTH and 
estrogen could explain 36% of the variation in calcium absorption occurring during weight 
loss in postmenopausal women (Cifuentes, Riedt et al. 2004). Serum cortisol levels may 
increase with weight loss in postmenopausal women, and this might increase osteoclast 
activity and decrease calcium absorption from the intestine (Riedt, Cifuentes et al. 2005). 
Elevated levels of glucocorticoids in cachectic and anorexic patients may also contribute to 
ongoing proteolysis and impaired protein synthesis (Morley, Thomas & Wilson 2006). The 
bone trophic factors such as insulin-like growth factor-1 (IGF-1) and PTH exert synergistic 
effects on bone (Lombardi et al. 2010). Obesity may also be associated with increased 
cortisol levels (Alfonso, Araki & Zumoff 2013). In both anorectic and obese patients, IGF-1 
levels are decreased, whereas growth hormone levels are elevated and this leads to an 
acquired growth hormone resistant state (Galli et al. 2012, Chaves, Junior & Bertolini 2013). 
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Chronic inflammation may also explain the detrimental effect of VAT on bone health 
(Shapses, Sukumar 2012). Obesity may be also associated with hyperinsulinemia, which in 
turn exerts an anabolic effect on bones although, both type 1 and 2 diabetes may also be 
predisposed to suffer impaired bone quality and an increased risk of fragility fractures 
(Hamann et al. 2012). 
The adipocytokines play a central role between adipose tissue and bone mineral 
measurements. A recent meta-analysis summarized that adipose-derived adiponectin was 
negatively associated with BMD and leptin was positively associated with BMD and even 
with some fractures, whereas the effect of ghrelin, apelin, resistin and visfatin on bone 
mineral measurements were negligible (Biver et al. 2011). The effects of leptin on bone are 
mediated through several pathways. First, leptin reduces serotonin levels, and this in turn 
leads to an activation of the β2-adrenergic receptors of the sympathetic nervous system as 
well as the osteotesticular phosphatase-gene, which decreases the production of osteocalcin 
(OC) in the osteoblasts and thus reduces bone formation. The reduced OC levels reduce 
adiponectin levels, prevent the secretion of insulin and reduce insulin sensitivity. Secondly, 
leptin inhibits bone resorption by activating the hypothalamic cocaine-amphetamine-
regulated transcript, by increasing OPG levels and, thus, OPG binds RANK-ligand directly 
to block its interaction with RANK. Finally, leptin directly reduces insulin secretion. Insulin 
triggers a decrease in OPG expression and enhances bone resorption and OC 
decarboxylation. Furthermore, leptin, produced from bone marrow adipocytes, can directly 
affect the proliferation and differentiation of osteoblasts, promoting bone nodule formation 
and exert indirect influences through sympathetic signalling to osteoclasts (Schwetz, Pieber 
& Obermayer-Pietsch 2012). Several gut peptides (e.g., glucagon-like peptide-2) may 
explain why feeding reduces bone resorption and to some extent increases bone formation 
(Dicembrini, Mannucci & Rotella 2012). Interestingly, the feedback system between bone-
derived osteokines (e.g., OC and osteopontin) and adiposity may maintain the homeostasis 
between optimal body weight and adequate BMD levels (Gomez-Ambrosi et al. 2008). 
The differentiation of mesenchymal stem cells into different kinds of specific cells such as 
adipocytes, osteoblasts or myoblasts is regulated by several transcription factors with 
peroxisome proliferator activator gamma playing a crucial role in this respect (Wei, Wan 
2011). Similarly thiazolidinediones, orally active antidiabetic agents, affect stem cell 
differentiation and consequently are associated with a shift towards lower body fat 
distribution, but with the consequence of increased body weight (Schwartz, Sellmeyer et al. 
2006). However, these agents decrease bone mass, and this is accompanied by an increased 
risk of atypical fractures and increased bone marrow fat accumulation (Grey et al. 2012, Liu, 
Aronson & Lecka-Czernik 2013). Interestingly, mesenchymal stem cells facilitate adipose 
accretion in bone marrow at the expense of osteoblast formation in osteoporotics (Zhang, 
Zhou & Kimondo 2012). However, it is not well known what genes link obesity to BMD 
values (Fromm-Dornieden et al. 2012, Mendez et al. 2013). Fat mass and obesity associated 
genes, have been proposed to link obesity to hip osteoporosis in an Asian population (Guo 
et al. 2011). 
2.4.6 Adiposity and biochemical markers of bone turnover 
The levels of bone formation markers (such as bone alkaline phosphatase (mineralization) 
and OC (mineralization, non-collagenous) and procollagen type I C and N-terminal 
peptides (PICP and PINP, type 1 collagen synthesis in fibroblasts and osteoblasts)) have 
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been inversely associated with obesity (Papakitsou et al. 2004, Grethen et al. 2012). Thus, 
obesity has been shown to suppress the formation of new collagen molecules (Papakitsou et 
al. 2004). Serum PICP may be more related to BMI than to bone formation markers, which 
are better associated with mineralization (Papakitsou, Margioris et al. 2004). The level of 
OC was inversely associated with total and trunk FM in postmenopausal women 
(Kanazawa et al. 2011). Bone resorption markers such as tartrate-resistant acid phosphatase 
(TRACP) and markers of collagen hydrolysis (pyridinoline, deoxypyridinolin, urinary and 
serum N- and C-terminal cross-linking telopeptide of type 1 collagen (NTX, CTX) inversely 
associated with BMI (Cifuentes et al. 2003, Ardawi et al. 2010). However, not all studies 
have detected an association between bone formation (alkaline phosphatase S-OC) and 
resorption markers (s-TRACP-5b, NTX, CTX, pyridinoline and deoxypyridinolin) and 
increasing adiposity (Papakitsou et al. 2004, Kumar et al. 2013). The disease, anorexia 
nervosa, is associated with extensive bone resorption, OPG and RANK-ligand and low 
bone formation levels but the changes in bone biochemical markers are reversed with 
weight gain (Ostrowska et al. 2012). Compared to normal weighted women morbid obesity 
was associated with lower vitamin D and higher PTH, bone formation (alkaline 
phosphatase) and resorption (NTX) markers (Grethen et al. 2011, Grethen et al. 2012). The 
weight loss occurring after morbid obesity is associated with an increase in both bone 
formation and resorption markers (Tsiftsis et al. 2009). In conclusion, it seems that being 
overweight is associated with lower bone formation and lower resorption, whereas women 
with extreme BMI values display disturbances in bone balance, i.e. women with anorexia 
nervosa as well as morbidly obese women have exhibited a relative increase in both bone 
resorption and formation markers. 
2.4.7 Adiposity and QUS 
There is controversy regarding QUS measured parameters (i.e. BUA and SOS) and 
anthropometrical measurements. Some have reported that anthropometrical parameters 
may be associated with both BUA and SOS values using either the DTU-One (OSI 
Osteometer Meditech) (Stewart et al. 2006) or the Achilles (GE Lunar) heel ultrasonometer 
(Brunner, Pons-Kuhnemann & Neuhauser-Berthold 2011). Many studies have found that 
anthropometrical values may be associated with BUA but not with SOS values (Hologic, 
Sahara) (Schoffl et al. 2008, Kauppi et al. 2009). BUA parameters were positively associated 
with body weight, whereas the association between SOS and body weight was inconsistent 
and depended on the age of the subjects (Stewart et al. 2006). Thus, body weight was 
positively associated with SOS values using both the Achilles (GE Lunar) and the Ubis 5000 
(Diagnostic Medical Systems) in elderly subjects but body weight was not associated with 
SOS values in younger subjects (Stewart et al. 2006). Stiffness index (GE Lunar, Achilles) 
values were associated with body weight in both younger and older subjects (Stewart et al. 
2006). In contrast, an increase of local heel fat thickness underestimated heel SOS, but not 
BUA parameters (McCue Ultrasonics, CUBA and GE Lunar, Achilles) (Kotzki et al. 1994, 
Hausler, Rich & Barry 1997). Thus, it seems that BUA values are associated with body 
weight, but not with the local heel adipose tissue. Furthermore, the local heel fat affects 
negatively SOS values, but the effect of overall adiposity on SOS parameters depends on 
which QUS device is being used and the age of subjects. Furthermore, both body 
composition parameters (FM and LBM) seem to influence BUA but not SOS values (McCue 
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ultrasonics, CUBA) (Tromp et al. 1999). There are also contradictory findings regarding the 
association between LBM and QUS parameters. Brunner et al. suggested that it is LBM 
rather than FM which can affect QUS parameters in elderly women (GE Lunar, Achilles) 
(Brunner, Pons-Kuhnemann & Neuhauser-Berthold 2011). In contrast, LBM was associated 
with QUS parameters (Hologic Sahara) in premenopausal women, but not in 
postmenopausal women (Saadi et al. 2003). 
In elderly lean (BMI ≤ 25.1 kg/m2) Finnish women, but not in heavier subjects, lifelong 
recreational physical activity, low physical activity at work, type 2 diabetes and 
hypertension were associated with increased BUA values, whereas high coffee intake was 
associated with lower BUA values (Korpelainen et al. 2003). 
2.4.8 Body weight and fractures 
The incidence of fall injuries is higher in obese individuals as compared to the normal 
weight population, which may be partly explained by the presence of comorbidities such as 
diabetes and various arthropathies, relative immobility and requirement of greater 
attentional resources to maintain postural stability (Mignardot et al. 2010). Although 
traumatic forces increase with body weight, the greater soft tissue padding around greater 
trochanter can diminish impact forces by up to 50% during a fall involving the greater 
trochanter and thus this can reduce the incidence of pelvis and hip fractures (Bouxsein et al. 
2007, Beck et al. 2009). According to a meta-analysis, the reduction of fracture risk ratio per 
unit increase in BMI was 0.98 (0.97-0.99, 95% confidence interval, CI) for any fracture, 0.97 
(0.96-0.98, 95% CI) for osteoporotic fracture and 0.93 (0.91-0.94, 95% CI) for hip fracture. The 
effect of BMI on all osteoporotic fractures seems to be mediated mainly through its effect on 
BMD, whereas the protective effect of BMI on hip fractures is independent of the effect of 
BMD. The association between fractures and BMI is not linear because a BMI of 20 kg/m2 as 
compared with a BMI of 25 kg/m2 was associated with a near doubling of hip fractures, 
whereas a BMI of 30 kg/m2 compared with a BMI of 25 kg/m2 was associated with only a 
17% reduction in the hip fracture risk (De Laet, Oden et al. 2005). Overweight and obesity 
reduced the risk of distal forearm fractures by 27% and by 56% compared to women with a 
BMI less than 25 kg/m2, respectively (Honkanen et al. 2000) Obese women had 20% lower 
risk of wrist fracture compared to non-obese women (Compston et al. 2011). The lowest 
body weight or BMI quartile when compared to the highest quartile displayed a 40% 
increase in vertebral fractures after adjustment for spinal BMD (van der Klift et al. 2004). 
Higher body weight and FM were associated with an 85% and a 6-fold reduction in 
vertebral fractures (Finigan et al. 2008). A 10% general weight loss (difference between 
maximum self-reported body weight and measured baseline body weight) was associated 
with a 2-fold increase in hip fracture rates, whereas in the women in the lowest tertile of 
BMI who lost 10% of their body weight suffered a 2.4-fold increase in hip fractures 
(Langlois, Mussolino et al. 2001). Measured general weight loss of 5% or more increased the 
risk of distal forearm fractures by 33% (Omsland et al. 2009). It has been reported that the 
FRAX predicts hip and major osteoporotic fractures in both obese and non-obese 
postmenopausal women (Premaor et al. 2012). The 10 year hip fracture probability is 4.1% 
without BMD (4.1% with a T-score of -2.8 SD) for women over the age of 65 in those with a 
BMI of 20 kg/m2, 2.3% (4.4% with BMD) with a BMI of 25 kg/m2, 1.7% (4.2% with BMD) 
with a BMI of 30 kg/m2, 1.4% (3.8% with BMD) with a BMI of 35 kg/m2 and 1.2% (3.5% with 
BMD) with a BMI of 40 kg/m2 according to FRAX, respectively (Kanis et al. 2008b). Every 5 
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kg/m2 increase in BMI reduced hip fracture risk by 20%, clinical spine facture by 17% and 
wrist fracture by 12% according to the Global Longitudinal study of Osteoporosis in 
Women (Compston et al. 2014). Finally, obese postmenopausal women showed a 63% 
lower risk of wrist fracture and 77% lower hip fracture risk compared to leaner women in 
the Million Women Study (n=1,155,304) (Armstrong et al. 2012). Thus, prior fracture, 
maternal fracture history, age and low body weight are the best predictors of fracture risk 
(LaFleur et al. 2008). 
According to the National Institute of Health and Clinical Excellence, obese and 
morbidly obese women under 75 years of age may also suffer from osteoporosis with a 
prevalence of 11.7% and they have a 4.5% prevalence of suffering low-trauma fractures 
(Premaor et al. 2010). Obese postmenopausal women who sustain nonvertebral fractures 
have a lower BMD on average compared to obese women without fracture (Premaor et al. 
2011). The risk of osteoporotic fractures was lower (Hazard ratio 0.87 (0.85-0.90, 95% CI) in 
women with a BMI of 35 kg/m2 as compared to women with a BMI of 25 kg/m2. However, 
obese women exhibited a 16% higher risk of osteoporotic fractures compared to women 
with a BMI of 25 kg/m2 after adjustment for BMD (Johansson et al. 2013). In particular, the 
central body fat distribution has been associated with a higher hip fracture incidence (65% 
difference between highest and lowest quintile after adjustment for BMI) because of an 
increased falling tendency, a greater momentum developed during the fall and less soft 
tissue covering the hip (Parker et al. 2008). Obesity has been shown to increase the risk for 
proximal humerus fracture by almost 30% compared to normal- or underweight women 
(Prieto-Alhambra et al. 2012). Compared to lean postmenopausal women (BMI<20 kg/m2), 
obese postmenopausal women (BMI≥30 kg/m2) had a three-fold increased risk of suffering 
an ankle fracture in the Million Women Study (Armstrong et al. 2012). Furthermore, there 
are several reports that obesity increases the incidence of fractures in the upper leg and the 
ankle with increases reported in the range from 50 to 69% (Valtola et al. 2002, Compston et 
al. 2011). Furthermore, every 5 kg/m2 increase in BMI increased ankle fracture risk by 5% 
(Compston et al. 2014). Interestingly, in postmenopausal women with osteoporosis, higher 
BMI was associated with a 4.5% higher vertebral fracture risk in a cross-sectional study, 
irrespective of the positive association between body weight and BMD (Pirro, Fabbriciani et 
al. 2010). However, body weight was not associated with any increased risk of osteoporotic 
fractures in perimenopausal women (Huopio, Kröger et al. 2000). Similarly, spine, wrist, 
tibial, and multiple rib fracture rates were not associated with BMI (Prieto-Alhambra et al. 
2012). 
2.5 ACCURACY, PRECISION AND CROSS-CALIBRATION OF 
DENSITOMETRY 
2.5.1 Accuracy and precision of densitometric measurements 
The accuracy (i.e. bias) of DXA reflects the degree to which the measured results of BMD 
deviate from true values. The true values are obtained by ashing of the bone (BMC, grams) 
under standard conditions and plain radiographs (area). The accuracy error of DXA devices 
is said to vary from 5 to 10% (Blake, Fogelman 2008). This error maybe explained by factors 
such as uncertainties in machine calibration, poor positioning, analysis, use of different 
edge-detection algorithms and most importantly the algorithms used by the device for 
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handling intra- and extra-osseous fat. Accuracy is important when comparing density 
values measured with different techniques or devices, as well as in determining an initial 
diagnostic classification. However, provided that it remains constant, a small accuracy error 
is of marginal clinical significance. In contrast, random errors (i.e. precision) that reflect the 
repeatability of the DXA or QUS technique are clinically more relevant (Blake, Fogelman 
2008). For example, as the population SD for some SOS measurements is relatively narrow, 
a technique with poor precision may lead to misinterpretation of the diagnostic results. 
Precision is affected by fluctuations in the operating characteristics of the device over time, 
operator errors in positioning patients and data analysis. The precision error helps in the 
decision making of whether a significant change has occurred in follow-up measurements. 
The short-term coefficients of variation (CV% = (SD/Mean) x 100%), a measure for precision 
error, and radiation doses for different regions of interests (ROIs) and imaging modalities 
are shown in table 4 (Blake, Fogelman 2001, Blake, Fogelman 2007). The short-term in vitro 
precision is achieved by scanning the manufacturer’s quality control phantom 10-20 times 
(Patel et al. 2000). The short-term in vivo precision of repeated measurements (instrumental 
errors) is measured after repositioning (positioning errors) the patient during the same visit 
or during a maximal period of two weeks, during which time no true change can occur in 
BMD. However, total hip and spine short term in vivo precision errors are greater when the 
scan-pairs are acquired on different days as compared to repeated acquisitions made on the 
same day (Leslie 2008). Thus, variability attributable to either the operator or the subjects 
rather than machine performance can explain most of the error in measurements (Carbone 
et al. 2005). According to ISCD, at least 30 degrees of freedom (df = (number of 
measurements from each individual – 1) x number of individuals in the study) are needed 
in order to be sure that the estimated short-term precision error is statistically accurate, 
unbiased and has an adequate study power. Thus, 30 subjects should be measured twice or 
15 individuals evaluated three times in order to be sure that the upper limit of precision 
error (95% CI) is no more than 34% greater than the calculated value (Baim et al. 2005). 
 
Table 4. Precision error and effective radiation dose of different bone imaging modalities. 
 
Technique ROI Units 
reported 
Precision 
error (CV%) 
Effective 
dose (μSv) 
DXA AP spine BMD g/cm2 1 1-10 
DXA Proximal hip 
BMD 
g/cm2 1-2 1-10 
pDXA Heel g/cm2 1-2 0.1 
QUS Heel BUA dB/MHz 2-5 none 
QUS Heel SOS m/s 0.1-1 none 
 
It is often more relevant clinically to know the long-term precision (in vitro CV% = 
(standard error of the estimate i.e. SEE/Mean) x 100%) of the random measurements 
conducted over time periods of months or years (Patel et al. 2000). Furthermore, root mean 
square (RMS) is used to calculate the in vivo short-term precision error (CV% = (RMS 
SD/Mean) x 100%) and the long-term precision error (CV% = (RMS SEE/Mean) x 100%), 
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respectively (Cawte et al. 1999, Diessel et al. 2000). Normally the long-term precision error 
(df = n x (m - 2)) is larger than the short-term precision error, due to small drifts in 
instrument performance, potential changes in patient weights and soft tissue composition, 
variations in patient positioning or other differences in technique that arise over time or 
between different personnel performing the test (Kiebzak, Morgan & Peace 2012). Obesity 
or large changes in body weight may influence the precision error of measurements, 
especially in individual patients (Patel et al. 2000, Nelson et al. 2010b). The relative (BMD in 
elderly is lower than in younger people) and absolute imprecision (difficulties in 
repositioning) increases when one deals with elderly subjects (Engelke, Glüer 2006). 
Furthermore, the in vivo imprecision obtained solely in young healthy subjects may be 
misleading (Engelke, Glüer 2006) as may direct comparisons of relative precision of 
different modalities or techniques (Engelke, Glüer 2006). If two instruments have the same 
CV%, then the device with a wider clinical range relative to the mean provides better 
clinical precision. Therefore standardized coefficients of variation (sCV% = (SD/clinical 
range) x 100) enable clinically more reliable comparisons of different DXA and QUS 
techniques and parameters (Diessel et al. 2000). However, the definition of sCV% varies. 
Some investigators use the 5th and 95th percentiles of the population under assessment 
(Miller et al. 1993), whereas other report the difference between the mean for healthy young 
adults and that for healthy individuals aged 70 and over (Blake, Wahner & Fogelman 1999). 
The latter calculation has been used for estimating sCV% in table 5 (Blake 1999). 
Standardized coefficients of variation show the inferior clinical precision (sCV%) of BUA 
and SOS measurements compared to DXA measurements. However, stiffness index 
improves the clinical precision over BUA and SOS alone, not only normalizing for heel 
width but also for the temperature dependence of the QUS measurements because 
temperature has opposite effects on BUA and SOS values (Nicholson, Bouxsein 2002). 
 
Table 5. Comparison of coefficients of variation (CV%) and standardized coefficients of variation (sCV%) of different DXA 
and QUS parameters. 
 
 DXA 
Spine BMD 
(g/cm2) 
DXA 
Hip BMD 
(g/cm2) 
QUS 
BUA heel 
(dB/MHz) 
QUS 
SOS heel 
(m/s) 
QUS 
Stiffness 
index 
Range of values 
(Osteoporotic –normal) 
0.9 – 1.2 0.7 - 1.0 100 – 125 1500 – 1560 67 – 100 
CV% 1.0% 1.2% 1.5% 0.3% 1.8% 
sCV% 4.0% 4.0% 7.5% 7.8% 5.4% 
 
Long-term in vivo precision error is typically about two times higher than the short-term 
precision error (Tothill, Hannan 2007). The typical in vivo long-term precision error for 
trimmed (untrimmed) data is obtained for lumbar spine BMD, 1.1% (1.7%); femoral neck 
BMD, 2.2% (2.5%); and total hip BMD, 1.3% (1.6%) (Patel et al. 2000). The lateral vertebral 
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body contains predominantly trabecular bone, whereas AP spine evaluates mostly the 
cortical posterior elements of the vertebrae. Therefore, lateral spine is less affected by the 
spinal degeneration of spinous process and aortic calcification (Chun 2011). Although 
lateral spine exhibits a stronger response to treatment compared to AP spine, this 
advantage is cancelled by the poorer precision (treatment effect/precision ratio) especially 
in elderly subjects (Blake, Herd & Fogelman 1996). The precision of DXA devices for 
measurement of LBM and FM has been reported to vary from from 0.4 to 1.3% for LBM and 
from 0.7 to 4.4% for FM (Toombs et al. 2012). The precision error of body composition 
measurements has improved with the arrival of newer DXA modalities, those are better 
than can be obtained with older DXA generations (Toombs et al. 2012). 
There are a few situations in which serial measurements of bone densitometry are 
routinely performed. The first is to monitor the effect of a therapeutic agent and to monitor 
the response to therapy. The second is to determine the point when the risk of an individual 
for low BMD warrants intervention or to undertake follow-up measurements in 
osteoporosis research. Least significant change (LSC) can help to determine reliably the 
appropriate interval of serial bone densitometry measurements for an individual in each 
ROI. For example, if the long-term in vivo precision error for BMD at the spine is 1.5%, to 
determine a LSC with 95% CI the bone density should change by 1.5 x 2.77, i.e. 4.2%, before 
this change can be considered as significant (Bonnick et al. 2001). Thus, in reality, the range 
of the 95% CI for a measured 6% change would be actually 6% ± 2.77, or 3.23-8.77% 
(Bonnick et al. 2001). The time interval for serial measurements is equivalent to LSC 
divided by the expected bone density change/year. If the precision error for AP spine DXA 
is 0.015 g/cm2, the LSC is 0.015 g/cm2 x 2.77 = 0.042 g/cm2 and if the expected average annual 
change in bone density with some agents is 0.03 g/cm2, then the time interval for repeated 
measurements will be 1.4 years (=0.042 g/cm2 divided by 0.03 g/cm2). A generalized least 
significant change can be used to compare results acquired with different densitometers 
(Shepherd, Lu 2007). When compared to women of normal body weight, obesity increases 
the precision error of spinal, femoral neck and total body BMD measurements significantly 
(Knapp et al. 2012). Consequently, serial measurements in obese women need to be treated 
with caution due to their larger than expected values of LSC (Knapp et al. 2012). 
The measured BMD changes of <2–4% in the spine and 3-6% at the hip could be due to 
an inherent measurement error in the DXA technology (NOF 2003). Thus, in clinical 
practice involving treatments with bisphosphonates an interval of 1-2 year and for HT 2-4 
years in measurements with central DXA from the first study can be recommended 
(Writing Group for the ISCD Position Development Conference 2004). During a period of 
rapid bone loss, such as that associated with prolonged glucocorticoid therapy, bone 
density may be monitored as frequently as every 6 months (Writing Group for the ISCD 
Position Development Conference 2004). Gourlay et al. have recommended rescreening 
intervals based on DXA measured T-score values: 15 years (T-Score ≤ -1.49), 5 years (T-score 
-1.50 to -1.99) and about 1 year (T-score -2.00 to -2.49) (Gourlay et al. 2012). However, to 
adhere overly strictly to such T-score based intervals may delay initiation of appropriate 
pharmacological therapy in some patients, especially if there are clear clinical risk factors 
present (Lewiecki, Binkley 2012). The higher the BMD and the greater time elapsing from 
menopause, the longer will be the time interval until a repeated measurement will be useful 
(Writing Group for the ISCD Position Development Conference 2004). 
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2.5.2 Uncertainties in DXA 
The role of DXA as a true golden standard for measuring bone health and fracture risk has 
been criticized (Adams 2013). DXA provides an areal BMD (g/cm2) parameter, instead of 
true volumetric bone density (g/cm3) acquired with CT devices (Adams 2009). Therefore, 
DXA sums up the two properties that determine bone strength, i.e., its material 
composition and its structural design (Currey 2009). Beam divergence produces a 
magnification error in the medial-lateral direction near the X-ray source of fan-beam 
densitometers. This affects the geometry of proximal femur and increases the bone area and 
BMC. However, the effect of magnification on clinically relevant BMD values is negligible 
(Toombs et al. 2012). The newer narrow fan-beam densitometers (e.g., GE Lunar Prodigy) 
are however less affected by the beam magnification than their older fan-beam counterparts 
(e.g., Hologic QDR-2000) (Toombs et al. 2012). Furthermore, DXA-measured BMD values 
are inherently higher in taller or larger individuals compared to smaller or shorter people, 
although their absolute bone density may be identical (Binkovitz, Henwood 2007). 
However, larger bones in general have greater strength and are less vulnerable to fragility 
fractures (Kanis et al. 2008a). DXA assumes that the hydration level of fat-free tissue is 73%. 
However, the hydration can actually vary from 67 to 85%. If the assumed level of hydration 
is exceeded, some DXA scanners will overestimate the fat content (Laskey 1996). Although 
Kelly et al. proposed that a range of fat-free tissue hydration from 68.2 to 78.2% does not 
significantly alter the total percentage of fat, (Kelly, Berger & Richardson 1998) severe 
overhydration, such as ascites or oedema, may affect the resulting percentage of fat or BMD 
(Guanabens et al. 2012). However, on some occasions, ascites has not interfered with 
measurement values (Haderslev, Svendsen & Staun 1999). Hip positioning (e.g., hip 
osteoarthrosis) can affect DXA measurements and manual selection of ROI may reduce the 
precision of measurements (Cetin et al. 2008). The precision and BMD values of the Expert-
XL device, but not those obtained with DXP-L or Prodigy devices, was found to be affected 
by room temperature (Culton, Pocock 2003). The presence of osteomalacia will 
underestimate total bone mass due to the decreased mineralization of the bone (Kanis et al. 
2008a). Metal objects, stones, implants, calcium tablets, movement during scan acquisition, 
contrast agents, scoliosis and aortic calcification can interfere with DXA measurements 
(Gregson et al. 2013). Degenerative changes (such as osteophytes and intervertebral 
arthrosis) as well as undetected/detected vertebral compression fractures incorrectly elevate 
spinal BMD values especially in the AP direction of many people older than 65 (Gregson et 
al. 2013). A manual data analysis, instead of one obtained via automation, may alter 
significantly results obtained from body composition measurements (Libber, Binkley & 
Krueger 2012). Antiresorptive treatment may reduce the risk of fracture by approximately 
50% due to redistribution of mineral when BMD increases only by about 5% (Seeman 2007). 
Thus, finite element analysis (FEA) of high-resolution micro CT device predicts fractures 
better than DXA and is more sensitive at detecting changes during osteoporosis treatment 
(Griffith, Genant 2011). Similarly FEA revealed that femoral bone strength decreased by 
55% with aging, whereas BMD decreased by only 26% (Keaveny et al. 2010). 
 
2.5.3 Uncertainties associated with adiposity and DXA 
DXA assumes that there is a homogenous distribution of soft tissue around the edge of the 
bone and uses this soft tissue density as its reference in the bone density measurements 
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(Bolotin et al. 2001). Unfortunately, alterations in tissue thickness and inhomogenous soft 
tissue composition adjacent to the bone may alter the X-ray beam attenuation, affecting 
adversely image information and potentially resulting in artificial changes in bone, 
especially in the lumbar spine (Bolotin 2007). A non-homogenous adipose distribution may 
confer a bias of 5% in the AP spine, 10% in the lateral spine and 6% in the femoral neck and 
total hip at least when using older DXA equipment (Tothill, Pye 1992, Svendsen et al. 1995) 
and 0.06 g/cm2 or 6% (hip) using modern DXA technology (Tothill, Weir & Loveland 2013). 
In individual cases the inaccuracy may be as large as 20-50% (Bolotin, Sievanen & Grashuis 
2003). Furthermore, even a homogenous soft tissue distribution may result in errors, 
especially with spinal BMD DXA-measurements (Bolotin 1998, Bolotin, Sievanen & 
Grashuis 2003). The relatively lower quantity of soft tissue (<10 cm) around skull, arms, ribs 
and legs may reduce the accuracy of soft tissue and bone measurement in these ROI’s 
(Lands et al. 1996). Increases in body thickness causes beam hardening (i.e. lower energy 
photons are attenuated from the radiation beam) and this reduces the accuracy of DXA 
measurements (LaForgia et al. 2009). In particular, AP abdominal body thickness of over 25 
cm (corresponds to a BMI of 45 kg/m2) overestimates BMD values (Blake, Fogelman 2008). 
For example BMD was overestimated by 20.5% after addition of three layers of fat adjacent 
to the bovine femur and the relative (%) overestimation of BMD increased with increasing 
surrounding lard (Javed et al. 2009). Thus, BMD may not lie on a truly linear scale and 
BMD may vary according to body thickness. Similarly densitometric inaccuracies may 
complicate reliable BMD diagnostics during weight changes (Bolotin, Sievanen et al. 2003). 
Fortunately, as compared to older DXA equipment, the newer imaging modalities (e.g., fan-
beam densitometer Lunar Prodigy) are less prone to errors of excess soft-tissue thickness in 
BMD measurements (Mazess et al. 2000). 
In the elderly, the red hematopoietic marrow (approximately 40% fat) is replaced by the 
yellow marrow (approximately 85% fat). In osteoporotic bone, the ratio of true bone tissue 
to bone marrow, which is normally about 75%, can also decline to a value as low as 25%. 
Thus, abnormal amounts of marrow fat and non-ossified bone tissue reduce falsely the 
measured bone density (Bolotin 2007). Alterations in bone marrow composition, especially 
during weight changes, may also diminish the reliability and precision of planar DXA 
measurements (Bolotin, Sievanen & Grashuis 2003). However, correction for bone marrow 
adiposity does not seem to improve spinal fracture prediction in Asian people (Blake et al. 
2009). 
The above adiposity-related DXA inaccuracies are similar to the typical changes 
encountered in longitudinal intervention studies and are, therefore, clinically relevant. 
Phantom studies have shown that spinal BMD inaccuracies can be as large as 25% for 
normal BMD values, 35% for osteopenic values and 50% for osteoporotic values. The 
inaccuracies in the values of distal radius and proximal femur BMD may be as great as 20% 
for normal BMD values, 25% for osteopenic values and 35% for osteoporotic values. The 
inaccuracy in BMD measurements conducted solely with cortical bone is less than 2% 
(Bolotin 2004). Thus, generally in individuals who are either overweight and underweight, 
the values of BMD will be overestimated and underestimated, respectively (Bolotin 2004), 
although sometimes the presence of adiposity underestimates BMD values (Yu et al. 2011). 
The association between the body fat distribution and BMD depends on both the selected 
DXA device and on the method of estimating the body fat distribution (Blake, Harrison & 
Adams 2004, Malouf et al. 2012). 
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According to Bredella et al., FM may be underestimated in large patients (Bredella et al. 
2010). The difference in the attenuation characteristics and in the hydrogen content of fat 
and lean tissues at the effective energy of the low energy beam in standard DXA can lead to 
inaccuracies because DXA simplifies the body into two compartments: bone and soft tissue. 
However, the attenuation coefficients of lean tissue and fat differ significantly, by about 
22% and 15% for the X-ray energies of 42 keV and 68 keV, respectively (Hakulinen et al. 
2003). Fat is less dense than lean tissue. Since bone free LBM is derived by subtracting the 
FM from the total soft tissue mass, the presence of a relative error in the estimation of the 
LBM (larger compartmental size) may cause a larger relative error in the FM (smaller 
compartmental size) (Pietrobelli et al. 1996). For example, Lunar iDXA has overestimated 
fat by up to 11.1%, but the relative overestimation of fat became less as the amount of fat 
increased in an experimental study (Javed et al. 2009). In fact, the normal three component 
DXA model of bone, LBM and FM (body composition parameters include also skin and 
water), should ideally separate bone, fat tissue, muscle tissue, water and yellow or red bone 
marrow tissue. 
In contrast to DXA instruments, the heel dual energy X-ray laser technique is able to 
minimize the effect of non-uniform soft tissue by taking the heel thickness into account 
(Hakulinen et al. 2003). The effect of overlying adiposity on in vivo spinal CT BMD is less 
prominent and more uniform as compared to spinal DXA measurements, although both 
techniques are significantly affected by adiposity. When compared to CT, DXA 
overestimated T-score values by 1-2 units in obese individuals (Weigert.J.M.:Cann.C.E. 
1999). DXA (Hologic Discovery) BMD increased with increasing adiposity (+12 kg) around 
the spine phantom, but the inclusion of lard did not affect CT BMD phantom 
measurements. In contrast, fat (+7.5 kg) reduced in vivo spinal BMD measurements by 2.2% 
but increased in vivo CT measurement values by 1.5%, respectively. The precision of DXA 
hip measurements was reduced with increasing adiposity, leaving unaffected total hip and 
femoral neck BMD values (Yu et al. 2011). Finally, there are reports that when using digital 
X-ray radiogrammetry, metacarpal BMD is also minimally affected by the presence of 
adjacent fat (Colt et al. 2010). 
2.5.4 Uncertainties in QUS technique 
Diffraction errors in BUA will be of the order of 0.6 and 10 dB/MHz for immersion (fixed 
transducer separation, water immersion) and contact measurements (gel coupling, 
transducer accommodating to heel width) on the heel, respectively (Langton, Njeh 2008). 
The overlying cortical surfaces can induce frequency independent interface losses of up to 
20 dB, as compared to pure cancellous bone (0.5 dB) (Langton, Njeh 2008). Phase-sensitive 
single element piezoelectric transducers (diameter larger than the wavelength of sound) 
limit the spread of ultrasound by diffraction. However, this leads to phase cancellation in 
the heterogeneous cancellous bone. If signals are out of phase then this will underestimate 
the true intensity of ultrasound and overestimate the attenuation, and this will result in an 
artificial increase of 8-20% in BUA (Wear 2007, Cheng et al. 2011). The cortical plate itself 
and the curved medial surface of the calcaneus also can induce phase cancellation (Xia, Lin 
& Qin 2005). Calcaneal edema has been shown to reduce BUA values in contact (gel) 
technique systems, but not in immersion (water surrounding limb) devices (Javaid et al. 
2005). The temperature of water correlated strongly negatively and moderately positively 
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with SOS and BUA, respectively (Nicholson, Bouxsein 2002). Foot positioning is probably 
the major cause of imprecision in clinical BUA measurement (Hans, Krieg 2009). 
The thickness of the heel bone and surrounding soft tissue remains either unknown or 
cannot be estimated reliably with the available QUS devices (Laugier 2008). Increase in heel 
thickness will underestimate SOS, whereas BUA values may be even slightly overestimated 
(Hausler, Rich & Barry 1997). Calcaneal length and heel width correlated significantly with 
QUS (Hologic Sahara) SOS and BUA values, respectively. The heel width also correlated 
significantly with Achilles + (Lunar) SOS, but not with BUA values (Cheng et al. 2002). 
Mapping of bone surface topology may improve the assessment of os calcis width as 
compared to assumptions about heel width incorporated into the conventional QUS 
techniques (Xia, Lin & Qin 2007). Although BUA and SOS depend on thickness of the 
calcaneus, the normalization for the width of calcaneus is not necessarily needed because 
the interindividual variation in heel width is small (Laugier 2008). Acoustic impedance of 
soft tissues is about 80% less than that of a typical bone (Chen et al. 2013). Measurement of 
heel SOS with an unknown soft tissue thickness has been shown to introduce an error that 
could be 3 - 20 times higher than the short-term precision error (CV% = 0.1%) (Chappard et 
al. 2000). An increase of fat thickness in the heel was reported to lead to an underestimation 
of SOS, but not of BUA parameters (Hausler, Rich & Barry 1997). Thus, BUA values are 
negligibly affected by local adiposity as the relative thickness of soft tissues in heel is small 
(Laugier 2008). Furthermore, the dual-frequency ultrasound technique may be applied to 
minimize the errors introduced by soft tissue (Malo et al. 2010). 
2.5.5 Cross-calibration of DXA machinery  
Aging or deficient DXA technology reduces the reliability of BMD measurement, 
necessitating a change of equipment. However, problems in maintaining the continuity of 
the BMD calibration scale can arise when an old DXA system is replaced by a newer model. 
Both body composition and bone mineral estimates are known to vary between DXA 
instruments from different manufacturers (Pearson, Horton & Green 2006). Furthermore, 
DXA densitometry results measured with equipment from different manufacturers may 
vary significantly due to technical differences and different normative values (Blake, 
Fogelman 2009). The mean BMD measured using Lunar Prodigy was 15% higher as 
compared to the same measurements performed with Hologic QDR2000. Even when using 
the standardized BMD, the mean difference was still 3% (Pearson, Horton & Green 2006). In 
addition, different versions of densitometers from the same manufacturer may differ 
significantly from each other (Blake, Harrison & Adams 2004). In the worst-case scenario as 
much as 5% differences may exist between the same types of machines from the same 
manufacturer (Gaither, Faulkner et al. 1996). However, typically less than 1% differences 
are encountered between similar or different machines from the same manufacturer (Blake, 
Harrison & Adams 2004, Shepherd, Morgan & Lu 2008). Although BMD values of two 
different DXA devices could be similar, the way that the two pieces of equipment handle 
different parameters of body composition may differ significantly (Covey et al. 2008). 
Routinely, daily scanning of phantoms is performed in order to check the reliability of 
the BMD calibration and to allow for correction of minor changes. However, a cross-
calibration of two DXA devices using only phantom measurements can be inaccurate, 
especially when performing hip ROI (Pearson, Horton & Green 2006). Nonetheless, 
sometimes in vivo and in vitro cross-calibration results agree between different 
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densitometers (Pearson, Cawte & Green 2002). Therefore, according to ISCD, phantom-
based cross-calibration is considered to be adequate after hardware change or after 
replacing the DXA system with an identical model from the same manufacturer, whereas in 
vivo cross-calibration is necessary if an old DXA system is being replaced with a different 
model from the same or a different manufacturer (Pearson, Horton & Green 2006). 
Correction coefficients are needed if the difference between the values of the two 
densitometers exceeds 1% (Shepherd et al. 2006). 
Cross-calibration between machines is important because mean systematic differences 
between instruments may exceed the annual biological changes in BMD values (Pearson, 
Horton & Green 2006). Usually scans from a minimum of around 20-30 subjects will be 
required during cross-calibration at each anatomical scan site to achieve an accuracy of ± 
1% (95% CI) and an evaluation of 50-100 subjects will be required to achieve an accuracy of 
± 0.5% (95% CI) (Shepherd et al. 2006). The statistical error of the intercept of each linear 
regression line is examined and, if the 95% CI includes zero (i.e. intercept is not statistically 
significant), the regression analysis is repeated with the intercept forced through the origin. 
If the slope (95% CI) of the regression line is statistically significantly different from unity, 
then the other device should be multiplied with this factor (Blake, Harrison & Adams 2004). 
It is not acceptable to simply report the Pearson correlation coefficient between the 
measurements with the two measuring devices (Bland, Altman 1986, Bland, Altman 2003). 
The difference between the two machines on the y-axis is recommended to be plotted 
against the average of the two measurements (x-axis) in order to detect any variation 
between measurements (Bland, Altman 1986, Bland, Altman 2003). Scan speed and body 
composition parameters need to be taken into account during a BMD cross-calibration 
procedure (Blake, Harrison & Adams 2004). Although the cross-calibration reduces the 
mean differences of two densitometers, systematic differences may remain between 
individual subjects even after cross-calibration (Pearson, Horton & Green 2006). 
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3 Aims of the study 
The aims of the study were: 
 
1. To evaluate the agreement between BMD measurements performed with Lunar 
DPX and DPX-IQ bone densitometers as well as to compare cross-calibration 
results acquired from human and phantom data. To calculate correction 
coefficients to attain comparability between DPX and DPX-IQ measurements as 
well as to evaluate and minimize the effect of BMI on this agreement. 
 
2. To assess the agreement between DXA and QUS techniques and to examine 
whether bone size and body composition or different normative values account 
for the discrepancies detected between different instruments. 
 
3 To determine the association between body fat distribution and 
postmenopausal BMD and to study how this is modified by HT. 
 
4.  To examine the effects of BMI on postmenopausal bone loss. 
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4 Subjects and methods 
4.1 STUDY DESIGN AND SUBJECTS 
4.1.1 Cross-calibration study (Study I) 
Most of the study population consisted of women recruited from the OSTPRE study (n=69). 
In addition, normal volunteers of younger age (n=20) were also included in order to cover a 
larger spectrum of bone densities. Eighty-eight and 89 women underwent hip and spinal 
BMD measurements, respectively. 
4.1.2 Study design and subjects (Studies I-IV) 
Figures 3 and 4 depict the selection process of the final study populations. 
 
 
Figure 3. Flowchart depicts the selection process of the final study populations II and III as a part of the Kuopio 
Osteoporosis-Fracture Prevention Study (OSTPRE-FPS) trial 
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Figure 4. Flowchart depicts the selection process of the final study population IV as a part of the population-based Kuopio 
Osteoporosis Risk Factor and Prevention Study (OSTPRE). 
 
4.2 METHODS 
4.2.1 DXA (Studies I-IV) 
In the OSTPRE study (Study IV), the baseline measurements of the AP lumbar spine (L2-
L4) and left hip (trochanter, ward and neck ROI’s) were carried out in 1989-91 and the 
follow-up measurements in 1994-98 using DPX at the Kuopio University Hospital. The 
third measurement was performed in 1999-2002 with DPX-IQ (Both of the above devices 
were provided by Lunar Corporation, Madison, WI, USA). Both devices use pencil-beam 
technology. The body weight limit recommendation (120 kg) set by the manufacturer was 
not exceeded. 
The agreement between DPX and DPX-IQ was measured during the same visit (Study I). 
Correction equations between the densitometers are described in detail in study I. In vitro 
short-term and long-term precision were calculated according to the methods of Glüer et al. 
(Glüer et al. 1995) and Blake et al. (Blake, Wahner & Fogelman 1999). 
In Study I, estimates for volumetric bone apparent mineral densities (vBMD; g/cm3) were 
calculated from the areal BMD values using the following formulas (Kröger et al. 1993): 
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lumbar spine vBMD = BMD (g/cm2) × (4 / (π × width of measurement area in lumbar spine)); 
femoral neck vBMD = BMD (g/cm2) × (4 / π) × (height of measurement area / measurement 
area of femoral neck). 
In OSTPRE-FPS study, the subjects (Study III) were measured from hip and AP lumbar 
spine as well as total and regional (head, chest, trunk, legs and arms) body composition 
with the fan-beam DXA (Prodigy, GE, Lunar, Madison, WI, USA). The pDXA measurement 
(Lunar PIXI Lunar Corporation, Madison, WI, USA), of the bare and clean left heel was 
performed at the OSTPRE-FPS baseline between February 2002 and May 2004 at the same 
time with central DXA measurements. PIXI uses a cone-beam technology with a charge-
coupled device area detector. 
Nonvalid bone (Studies II-IV, hip prosthesis, arthrosis, osteophytes, fractures, 
operations, sclerosis, scoliosis or other spinal deformities) or body composition (Studies II-
III, measurement area too narrow for the detector, pacemaker or vascular prosthesis) were 
excluded from the analyses. In addition, 9.3% of the measurement pairs of baseline lumbar 
BMC and scan area (Study IV) were lost due to a computer hardware error. 
4.2.2 QUS (Study II) 
Left foot calcaneal ultrasound measurement (Lunar Achilles, Lunar Corporation, Madison, 
WI, USA) was performed at the OSTPRE-FPS baseline at the same time with DXA 
measurements. Achilles uses an immersion technique. 
4.2.3 Postal questionnaires 
The baseline OSTPRE postal enquiry was mailed in 1989 and included data about 
medications, use of HT, gynecological history, history of fractures, weight, height, chronic 
health disorders diagnosed by a physician, nutritional as well as lifestyle factors (Appendix 
1).  
The second baseline questionnaire was sent to those who underwent densitometry 
during 1990-1991. It contained questions about the consumption of dairy products, alcohol 
and coffee. Both questionnaires were reviewed by a trained nurse in the presence of the 
participant at the baseline densitometry.  
The OSTPRE 5-year enquiry was sent in 1994 and the 10-year enquiry in 1999. The 
OSTPRE-FPS enquiry was sent in 2002 (Appendix 2). 
4.2.4 Body weight and height (Studies I-IV) 
Body weight (kg) and height (cm) were measured in light clothing without shoes at each 
densitometry with a calibrated scale and a wall-mounted stadiometer, respectively. 
4.2.5 Grip strength measurements (Study IV) 
Right hand grip strength was measured by trained nurses at baseline with a hand-held 
strain gauge dynamometer (Martin Vigorimeter, Tuttlingen, Germany) with the subject in a 
seated position with elbow flexed at a 90 degree angle and was not allowed to touch any 
part of the body. The resting time between subsequent measurements was 30 seconds and 
was taken to be the mean of 3 successful measurements. 
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4.2.6 Menopausal status (Study IV) 
A woman was regarded as postmenopausal if 12 months had elapsed since her last 
menstruation or if she had undergone bilateral ovariectomy. Women were regarded as 
perimenopausal if menopause occurred before the 2nd densitometry, early menopausal if 
they were ≤5 years postmenopausal and late menopausal if they were >5 years 
postmenopausal. 
4.2.7 HT use (Studies III / IV)  
In Study IV, users of HT were excluded and in Study III, women were divided into two 
groups according to their use of HT. The use of HT was calculated based on estrogens, 
progestagens, or their combination whether in tablets, transdermal gels or patches during 
the follow-up or past taken for menopausal symptoms. The vaginal route of administration 
(gel or pessary) was not considered as HT. Users of HT had been receiving HT either 
occasionally or continuously during or before the study period, whereas HT non-users did 
not use estrogen therapy either before or during the study. Information about the use of HT 
was obtained from the questionnaires. 
4.3 STATISTICAL METHODS 
All statistical analyses were performed using the Statistical Package for Social Sciences 
(SPSS, WI, USA, SPSS Inc.) for Windows software version 11.5. 
In Study I, the Pearson's correlation analysis, the paired samples T-test and the linear 
regression analysis were used to analyse the agreement between two densitometers. 
Similarly, the Bland and Altman method (Bland, Altman 1986, Bland, Altman 2003) was 
used to evaluate the bias in results between the devices. In the above method the mean of 
the differences of the two DXA scanners were plotted against the mean values of 
measurements. The limits of agreement were calculated with the formula: absolute mean 
difference (d) ± 1.96 SD. Relative mean differences (d%) were obtained by using the 
formula: [(DPX – DPX-IQ) × 100] / DPX-IQ. A test for significance of the slope coefficient's 
equality to one was used to estimate adequacy of sample size. Calculations were based on 
effect sizes with alpha=0.05 and power=80%. The accuracy of corrections, obtained with a 
regression line, was expressed as the s.e.e. In mathematical terms the s.e.e. equals the root 
mean square error (RMSE). 
In Study II, the continuous data were analysed by using the Pearson's correlation 
analysis and the linear regression analysis to establish the association and agreement 
between DXA and QUS machines. Statistical z-score transformations [z-score = (xi-
mean)/SD, where xi is the measured value for woman i] were used as a normalization 
procedure for the measured values for BMD and QUS parameters. The differences (d) 
between any two bone parameters were plotted against the anthropometric parameters and 
linear regression analysis was utilized to evaluate any systematic differences in the results 
between the measurements. 
In Study III, the data was analysed by using the stepwise linear regression and the 
Pearson's correlation analysis for continuous parameters as well as the T-test and univariate 
analysis of variance (ANOVA) with the least significant difference post hoc test for 
independent categorical parameters.  
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In Study IV, the repeated measures from the subjects were analysed applying mixed 
models framework in the form of random coefficients regression (Brown, Prescott 1999). 
DXA and body anthropometry measurements were modeled as a polynomial function of 
time (years since menopause or age) taking into account the intra-subject correlation of the 
measurements. The effect of continuous scale BMI was included into the model as a time-
varying covariate. In practice, this means that the actual BMI at each time point is 
considered as a predictor of the corresponding BMD. 
In all analyses, a p-value below 0.05 was considered to be statistically significant. 
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5 Results 
The main results of each study (I-IV) are presented in Table 6. 
 
Table 6. The main results of the studies I-IV. Effect of adiposity on DXA and QUS parameters in postmenopausal women. 
 
 
5.1 CROSS-CALIBRATION STUDY (STUDY I) 
There was a close linear relationship over the entire range of BMD values for the spinal 
(r=0.989) and femoral neck (r=0.966) scans between DPX and QPX-IQ densitometers. In all 
ROIs, the slopes of the regression lines were significantly different from unity, emphazing 
the need for using correction equations between the two densitometers. DPX-IQ measured 
lower BMD values than DPX in the lumbar spine (-0.012 g/cm2 i.e. -1.1%), in the Ward’s 
triangle (-0.016 g/cm2 i.e. -2.1%) and in the trochanter (-0.001 g/cm2 i.e. -0.1%) ROIs’ (Table 
7). In contrast, DPX-IQ measured higher BMD values than DPX only in the femoral neck 
(+0.013 g/cm2 i.e. +1.4%) ROI. In comparison, a typical difference in BMD values between 
GE Lunar Prodigy and iDXA devices ranged from 0.4% to 1.2% in the lumbar spine ROI 
and from 0.7% to 2.0% in the femoral neck ROI (Choi et al. 2009, Hind et al. 2013). On 
average women included in the NHANES 2005-2008 lost annually 0.0045 g/cm2 of the 
acquired femoral neck BMD between the age of 50 and 80 years (Looker et al. 2012a). Thus, 
a 0.013 g/cm2 difference in femoral neck BMD values between DPX and DPX-IQ devices in 
femoral neck ROI corresponds to almost a typical mean femoral neck bone loss during a 3 
year period. The difference between DPX and DPX-IQ scanners was minimal, after the 
application of simple and multivariate (including body weight or BMI) correction 
coefficients. Cross-calibration of lumbar spine BMD values was not affected by adiposity 
(Table 7). In overweight and obese women, DPX measured higher BMD values than DPX-
IQ, although on average, DPX-IQ measured femoral neck BMD values were higher 
compared to DPX (Figure 5A). There was practically no difference in mean femoral neck 
BMD values between the densitometers after simple BMD-correction was applied, but even 
Study Key variables Number of 
study 
subjects 
Main result 
I Central BMD 88-89 BMI affects in vivo cross-calibration between DPX 
and DPX-IQ DXA devices 
II Central BMD, heel 
BMD and heel QUS 
139 DXA, pDXA and QUS parameters are differently 
affected by adiposity 
III Central BMD 198 Central obesity is associated with spinal BMD, but 
not with hip BMD, irrespective of HT use 
IV Central BMD 300 Obesity delays the incidence of hip and spinal 
osteopenia 
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after conventional correction coefficients were applied the difference between the DXA 
devices was affected by adiposity (Figure 5B). The addition of BMI in the correction 
equation for femoral neck BMD values minimized the difference between the two 
densitometers (Figure 5C). However, the present results cannot be extrapolated to DXA 
devices from different manufacturers or even to different devices from the same 
manufacturer. The linear regression has been criticized because it assumes no random error 
in the dependent variable and tends to underestimate the slope of the true linear 
relationship (Pearson, Cawte & Green 2002). However, the two statistical methods (i.e. the 
standardized principal components analysis (Feldmann et al. 1981) and the linear 
regression analysis) yielded comparable results. The limits of agreement for lumbar spine 
(i.e. from -0.035 to 0.060) and femoral neck (i.e. from -0.075 to 0.050) BMD values were 
compatible in most ROIs or slightly wider in some ROIs compared to other reports (Choi et 
al. 2009, Hind et al. 2013). 
 
Table 7. Relative mean difference (d% (SD)) difference between DPX and DPX-IQ densitometers. 
 
  Original Simple Multivariate 
ROI  d% (SD)a d% (SD)b d% (SD)c 
Lumbar spine L2-L4     
 BMD -1.1 (2.5) 0.006 (1.046)  
 BMC -0.1 (3.8) -0.164 (3.837) 0.059 (3.452) 
 area 1.0 (3.0) -0.078 (3.015) -0.019 (2.656) 
Femoral neck     
 BMD 1.4 (1.9) -0.008 (3.284) -0.007 (3.205) 
 BMC 0.5 (1.2) -0.049 (1.743) 0.011 (3.511) 
 area -0.9 (2.8) -0.001 (10.011) 0.046 (9.442) 
Ward’s triangle     
 BMD -2.1 (1.3) -0.177 (0.595)  
 BMC -2.6 (11.7) 1.263 (23.821) 1.324 (23.122) 
 area -1.9 (0.02) 0.297 (17.434) 0.213 (16.559) 
Trochanter     
 BMD -0.1 (1.6) -0.009 (1.490) -0.088 (1.508) 
 BMC 1.3 (7.4) 0.532 (8.009) 0.291 (3.627) 
 area 1.6 (6.7) 0.284 (7.838) 0.275 (6.150) 
a Formula for relative mean difference (d%): [(DPX-IQ - DPX) × 100 / DPX]. 
b Formula for relative mean difference (d%): [(DPXsimple corrected - DPXoriginal) × 100 / DPXoriginal]. 
c Formula for relative mean difference (d%): [(DPXmultivariate corrected - DPXoriginal) × 100 / DPXoriginal]. 
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Figure 5. Scatter plot for the difference between Lunar DPX and Lunar DPX-IQ against BMI at femoral neck BMD (I). 
Comparison between (A) original BMD values; (B) corrected with simple linear regression (DPX BMD femoral neck = 
0.9861 × IQ BMD); (C) corrected with multivariate linear regression (DPX BMD femoral neck = 0.9605 × IQ BMD + 0.0018 × 
BMI - 0.0252) values. Mean difference (d) = straight line, limits of agreements (d ± 1.96 × SD) = dashed lines. N=88 (A to C). 
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5.2 THE EFFECT OF ADIPOSITY IN DXA, PDXA, AND QUS 
MEASUREMENTS (STUDY II) 
Mostly, DXA, pDXA and QUS parameters were positively associated with body size 
parameters. Only heel SOS and lumbar spine BMD values were not associated with body 
height (p>0.05) (Table 8). Femoral neck BMD and heel SOS values were not associated with 
adiposity (total body % fat, p>0.05, Figure 6 and Table 8). A moderate association was 
observed between lumbar spine or heel BMD and adiposity, thus total body % fat explained 
34% of the variation in the lumbar spine BMD and 27% in the heel BMD (p<0.05). Modest 
correlation was observed between two QUS parameters (BUA and stiffness index) and total 
body % fat (p<0.05) (Figure 6). Femoral neck T-score and Z-score values were not associated 
with relative (%) total body fat (Figure 7). T-score and Z-score values of pDXA and QUS 
were similarly affected by adiposity, whereas the association between lumbar spine T-score 
values and adiposity was stronger than the association between Z-score values and fatness 
(Figure 7). With respect to the anthropometrical parameters, body weight was the strongest 
determinant of DXA, pDXA and QUS parameters (Table 8), whereas for the body 
composition parameters (FM and LBM), higher LBM was also associated with higher 
femoral neck and lumbar spine BMD values in the multivariate model but not with pDXA 
or QUS values. The mean T-score value was -1.1 SD in three ROIs (i.e. lumbar spine, 
femoral neck and heel QUS), whereas the mean T-score value measured with pDXA was  
-0.3 SD in heel ROI.  
However, of all anthropometrical parameters (i.e. height, body weight, BMI, FM (kg), 
LBM (kg) and total body % fat), body weight was the strongest and the only determinant of 
normalized bone parameters in all ROIs (p<0.05), except in heel SOS ROI, where none of the 
anthropometrical variables were included in the final model (p>0.05) (method linear 
regression, data not included in the original publication). Maximum grip strength value of 
three successful measurements was included with body weight in the final multivariate 
model only in normalized lumbar spine and heel pDXA ROIs. Furthermore, only heel SOS 
was not associated with total body FM (kg) (p>0.05), whereas in femoral neck ROI BMD 
values were positively associated with total body FM (kg) (Table 8). Of the body 
composition parameters (FM (kg), LBM (kg) and total body % FM) FM (kg) was the 
strongest and only determinant of normalized heel BUA, heel stiffness, heel BMD and 
lumbar spine BMD values (p<0.05), whereas LBM (kg) was the only body composition 
variable associated with normalized femoral neck BMD values (p<0.05) (method linear 
regression, data not included in the original publication). 
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Figure 6. The association between relative (%) total body fat and normalized (z-score = (xi-mean)/SD, xi=measured value)) 
central DXA, heel pDXA and heel QUS measurement values (n=139). 
 
 
 
Figure 7. The association between DXA, pDXA and QUS measured T-score (A) and Z-score (B) values with relative (%) 
total body fat. 
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Table 8. Linear correlation coefficients (r) between anthropometric parameters and normalized results of QUS and DXA 
measurements. *p<0.05, **p<0.01, ***p<0.001. 
 
Device Prodigy-DXA PIXI-pDXA Achilles-QUS 
ROI Lumbar Spine 
BMD 
Femoral Neck 
BMD 
Heel 
BMD 
Heel 
SOS 
Heel 
BUA 
Heel 
Stiffness 
Height (cm) 0.17 0.17* 0.20* 0.09 0.19* 0.18* 
Weight (kg) 0.41*** 0.29** 0.35*** 0.08 0.25** 0.21* 
BMI (kg/m2) 0.34*** 0.21* 0.27** 0.03 0.17* 0.13 
FM (%) 0.34*** 0.15 0.27** 0.08 0.18* 0.17 
LBM (kg) 0.21* 0.23* 0.21* 0.03 0.05 0.12 
FM (kg) 0.39*** 0.23* 0.33*** 0.07 0.23** 0.20* 
 
5.3 THE EFFECT OF CENTRAL OBESITY AND HT ON BMD MEASUREMENTS 
(STUDY III) 
The ever users of HT were thinner, had less both trunk FM and total body LBM, and had 
higher femoral neck and lumbar spine BMD values as compared to never users of HT 
(Table 9). Lumbar spine T-score values, but not femoral neck T-score values, were affected 
by trunk fat (Figure 8). Thus, trunk FM and use of HT were included in the final 
multivariate model in the lumbar spine ROI, whereas body weight and use of HT best 
explained femoral neck BMD values (p<0.05). There was no interaction between the use of 
HT and trunk fat (linear regression, p = 0.408) implying that the effect of trunk fat on spinal 
BMD values was independent of the use of HT. T-score values in lumbar spine ROI were 
1.0 SD lower in the lowest trunk FM tertile compared to the highest tertile, whereas the 
difference was 0.7 SD between the middle and the highest trunk FM tertiles (p<0.05). 
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Table 9. Mean values (SD) and range for the anthropometric and DXA parameters in the Kuopio Osteoporosis-Fracture 
Prevention (OSTPRE-FPS) Study population (III, n=198). Differences (in variables) between never and ever users of HT are 
marked with an asterisk. Student’s T test: *p<0.05, **p<0.01, ***p<0.001. 
 
 
 
 
Figure 8. The association between the trunk FM (kg) tertiles (III) and A) postero-anterior lumbar spine (L2-L4) and B) 
femoral neck T-score values. The results are adjusted for body weight. Method: Univariate Anova using least significant 
difference post hoc tests with the rightmost (=lowest) tertile III as reference. P-value: *p<0.05, **p<0.01, ***p<0.001. Tertile 
limits for the 1st (from 14.7 to 24.9 kg), the 2nd (from 11.1 to 14.7 kg) and the 3rd (from 2.5 to 11.1 kg) trunk FM tertile. 
Standard errors are shown with error bars. 
 
 
 Never HT 
(n=96) 
Ever HT 
(n=102) 
Total population 
(n=198) 
 Mean (SD) Mean (SD) Mean (SD) Range 
Anthropometry     
Age (yr) 67.6 (1.8) 67.4 (1.9) 67.5 (1.9) 65.3 – 71.7 
Height (cm) 158.4 (4.9) 159.0 (4.7) 158.7 (4.8)  144.6 – 171.3 
Weight (kg) 69.5 (11.1) 66.9 (8.7) 68.1 (10.0) 43.7 – 93.7 
BMI (kg/m2) 27.7 (4.4)* 26.4 (3.2) 27.1(3.9) 19.2 – 40.9 
Body composition     
Total body LBM (kg) 40.1 (3.8)* 39.0 (3.2) 39.6 (3.5) 31.3 – 50.1 
Total body FM (kg) 26.6 (8.2) 24.8 (6.6) 25.7 (7.4) 7.7 – 47.8 
Leg FM (kg) 9.3 (2.9) 9.1 (2.5) 9.2 (2.7) 3.8 – 18.3 
Trunk FM (kg) 13.7 (4.9)* 12.4 (3.9) 13.1 (4.4) 2.5 – 24.9 
Trunk-leg FM ratio 1.5 (0.5) 1.4 (0.4) 1.5 (0.4) 0.5 – 3.2 
DXA     
Lumbar Spine BMD (g/cm2) 1.020 (0.160)*** 1.111 (0.164) 1.067 (0.168) 0.643 – 1.502 
Femoral Neck BMD (g/cm2) 0.828 (0.101)*** 0.884 (0.110) 0.857 (0.109) 0.610 – 1.189 
Lumbar Spine T-score -1.4 (1.3) *** -0.7 (1.4) -1.0 (1.4) -4.6 – 2.6 
Femoral Neck T-score -1.3 (0.8) *** -0.8 (0.9) -1.0 (0.9) -3.1 – 1.7 
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5.4 OVERWEIGHT AND PROGRESS OF BONE LOSS (STUDY IV) 
On average, women were overweight (BMI 27.3 kg/m2), although there was wide variation, 
ranging from women who were underweight to morbidly obese women (BMI range from 
18 kg/m2 to 44.9 kg/m2) in the present study population (n=300). The mean weight gain was 
3.6 kg and mean height loss was 1.3 cm during the average 10.5-year follow-up. There was 
considerable variation in weight ranging from a maximum weight loss of 17 kg to a 
maximum weight gain of 29 kg. At baseline (Table 10), the prevalence of osteopenia was 
37.7% and that of osteoporosis was 5.3% in the lumbar spine (L2-L4), and 29% and 0% 
respectively in the femoral neck (based on manufacturer’s T-score values). At the third 
DXA-measurement, the corresponding percentages were 44.7% and 10% for the spine and 
57% and 1% for the femoral neck. The mean annual bone loss rate was -0.70% (SD 0.60) at 
femoral neck and -0.37% (SD 0.62) at lumbar spine during the average 10.5 year follow-up. 
A second-order model described best the age-related progress of bone loss in both femoral 
neck and lumbar spine, but only in the lumbar spine menopause-related bone loss was 
depicted best by the second-order model (Figure 9). Three clinically important BMI cut-off 
values (20, 25 and 30 kg/m2) were selected from the continuous data. The actual follow-up 
time (10.5 years) was only half of the 20 years of postmenopausal bone loss in figures 9 and 
10 due to differences in menopausal status at baseline and variations in follow-up time. 
Women with a BMI of 20 kg/m2 became osteopenic 2 years (spine) and 4 years (femoral 
neck) after menopause on average, whereas women with a BMI of 30 kg/m2 became 
osteopenic 7 years (spine i.e. 5 years later) and 13 years (femoral neck i.e. 9 years later) after 
menopause on average (Figure 9). Women with a BMI of 20 kg/m2 became osteopenic at the 
age of 51.5 years (spine) and 53.5 years (femoral neck) on average, whereas women with a 
BMI of 30 kg/m2 became osteopenic at the age of 55.5 years (spine i.e. 4 years later) and 61.5 
years (femoral neck i.e. 8 years later) on average (Figure 10). 
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Table 10. Baseline characteristics of the study population sample (IV, n=300) from the Kuopio Osteoporosis Risk Factor and 
Prevention (OSTPRE) Study. 
 
Characteristics Mean (SD) Range 
     Age (yr) 53.6 (2.8) 48.4 – 59.0 
    Follow-up time (yr) 10.5 (0.5) 9.4 – 12.9 
    Years since menopause 2.9 (4.3) -5.0 – 19.2 
    Height (cm) 161.1 (5.0) 150 – 174 
    Weight (kg) 70.7 (11.6) 48 – 115 
    BMI (kg/m2) 27.3 (4.4) 18.0 – 44.9 
    Lumbar spine BMD (g/cm2) 1.117 (0.144) 0.625 - 1.646 
    Femoral neck BMD (g/cm2) 0.933 (0.116) 0.679 - 1.329 
    Trochanter BMD (g/cm2) (n=299) 0.853 (0.126) 0.571 - 1.298 
 n % 
BMI kg/m2   
 <20 (underweight) 5 1.7 
 20–24.9 (normal weight) 98 32.3 
 25–29.9 (overweight) 132 44.0 
 30–39.9 (obese) 62 20.7 
    >40 (severely obese) 3 1.0 
Menopausal status   
    Peri: menopause before 2nd densitometry 93 31.0 
    Early: ≤ 5 years postmenopausal 125 41.7 
    Late: >5 years postmenopausal 82 27.3 
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Figure 9. The relationship between three selected cut off-values for BMI and T-score by years since menopause of the (IV) 
A) AP lumbar spine (n=300) and B) femoral neck (n=300) with linear mixed model method. The horizontal straight line 
indicates cut-off point (-1 SD) for osteopenia. 
 
 
 
 
Figure 10. The relationship between three selected cut off-values for BMI and T-score by age of the (IV) A) AP lumbar 
spine (n=300) and B) femoral neck (n=300) with linear mixed model method. The horizontal straight line indicates cut-off 
point (-1 SD) for osteopenia. 
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6 Discussion 
6.1 STUDY DESIGN AND METHODS 
The OSTPRE cohort included all of the women born between 1932-1941, aged 47-56 years at 
baseline in 1989 from a defined geographic area, Eastern Finland. The women of the 
OSTPRE-FPS-study were aged 65 or over at baseline in fall 2002. The study populations are 
Caucasian and homogenous. Thus, OSTPRE and OSTPRE-FPS cohorts are considered to 
represent quite well the general Finnish-speaking majority of the Finnish population. 
The original study cohorts consisted of a random sample as well as a stratified sample of 
women belonging to the same population base. A selection bias cannot be ruled out as the 
women were offered an opportunity to volunteer to undergo DXA measurements 
(Bhandari et al. 2003). Overall, with respect to the OSTPRE and OSTPRE-FPS cohorts, 92% 
and 77.4% responded to the baseline inquiry, and then 84% and 59.8% were willing to 
participate in bone densitometry, respectively. With respect to the OSTPRE and OSTPRE-
FPS populations, 67.5% (51.6% completed all three densitometric measurements) and from 
14.4 to 20.3% underwent densitometric or body composition measurements, respectively. 
Thus, especially in the OSTPRE-FPS a smaller proportion of women were selected for bone 
densitometry. Finally, the loss of women during the several stages of selection procedure 
for bone densitometry and those providing random samples was either small or moderate 
at each individual stage. Nonetheless, the overall loss was considerable. This loss of 
participants may have resulted in an overrepresentation of healthier women in the samples 
(Leslie, Tsang & Lix 2008). Some of the body composition measurements were not available 
at the time of the analysis of Study II data, thus reducing the size of that study’s final 
population. 
Responses to postal questionnaires were partially checked at the time of bone 
densitometry. Incomplete or ambiguous data have thus been corrected over the telephone 
during the coding phase. The information on postal inquiries could not be fully validated 
and some errors may have remained in answering or coding. 
Errors due to measurement technique were minimized by using specially trained 
personnel and by the regular use of phantom measurements. The long-term precision 
(coefficient of variation, CV%), based on regular measurements of an anatomical Hologic 
spine phantom, was 0.88% and 0.62% with DPX (10/1994-4/1999) and DPX-IQ (4/1999-
10/2003), respectively. The short-term in vivo repeatability has been shown to be 0.9% for 
the spine and 1.5% for the femoral neck (Kröger et al. 1992, Komulainen et al. 1998). 
Although the DXA device was changed during one study (Study IV), a comparison was 
performed and correction coefficients were applied to minimize the bias (Study I). 
However, measurement errors cannot be fully eliminated. 
In the cross-calibration Study I, the study population of 88-89 women clearly exceeds the 
recommended minimum of 20-30 subjects (Shepherd, Morgan & Lu 2008). Further, most of 
the study population consisted of women recruited from the OSTPRE study (n=69), 
however, normal volunteers of a younger age (n=20) were also included in order to gather a 
larger spectrum of bone densities and measurement age in our OSTPRE study. Thus, the 
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generalizability of the cross-calibration results to the general Finnish population is quite 
good (Kröger et al. 1992). The densitometers which were cross-calibrated are also in clinical 
use in Kuopio University Hospital and are also used to monitor children’s bone densities. 
However, although volumetric densities were calculated because volumetric densities are 
used for the measurements of children, it cannot be ensured that these correction 
coefficients (BMD, BMC, area and volumetric BMD) apply to men, children or other races. 
The number of study subjects was small in Studies II, III and IV when compared to the 
original OSTPRE cohort. However, incorrect DXA measurements were excluded because 
they might spuriously elevate BMD values (Gregson et al. 2013). Users of HT, calcitonin 
and bisphosphonates as well women who were not postmenopausal during the second 
densitometry or whose menopausal status was not known were excluded in Study IV to 
ensure that the examination was following the natural progress of bone loss. However, 
women (n=66) with some other bone affecting medications or diseases (Kröger et al. 1994) 
were included in the study and were treated as a confounding factor. These diseases were: 
renal disease, liver disease, insulin-dependent diabetes, malignancies, rheumatoid arthritis, 
endocrine abnormalities (parathyroid/thyroid glands, adrenals), malabsorption (including 
lactose malabsorption), total/partial gastrectomy, alcoholism and long-term immobilization. 
Bone-affecting medication included corticosteroids, diuretics, cytotoxic drugs, 
anticonvulsive drugs, anabolic steroids and vitamin D. Selection of final study populations 
(Studies II-IV) might affect adversely on the generalizability of all results and some kind of 
selection bias cannot be ruled out (Bhandari et al. 2003). 
The categorization of women according to HT status was straightforward in Study III. 
However, the number of women would have been rather small to study the effect of 
duration of HT on central obesity and BMD, and thus we avoided the use of arbitrary cut-
off points. This would have reduced the study power considerably in the subgroup 
analyses, leading perhaps to false conclusions. Thus, the dose-response of HT on the 
relationship between central obesity and BMD could not be entirely verified. Furthermore, 
3105 women (27.3%) from a total of 11377 women reported the use of HT from the year of 
1996 to 1999. Of the self-reported users of HT, a total of 97.6% of the 3105 women were 
confirmed as HT users. In contrast, 15.2% of the women who reported no use of HT had 
been reimbursed and prescribed HT according to the Social Insurance Institution of Finland 
data (Kansaneläkelaitos) (Sandini et al. 2008). Unfortunately, it is not possible to evaluate 
how women actually used the prescribed and reimbursed HT. Thus, although some 
uncertainty remains about the use of HT, Greendale et al. have reported that spinal BMD 
values after short term use of HT (under 3 years) do not differ from the BMD values of 
never users of HT (Greendale et al. 2002). 
Study IV was based on prospective data, which avoids much of the inherent bias of the 
cross-sectional and retrospective studies. BMI was measured on each occasion, which 
reduces the risk bias. Repeated measures on the subjects were analysed by applying mixed 
models framework in the form of random coefficients regression (Brown, Prescott 1999). 
DXA and body anthropometry measurements were modeled as a polynomial function of 
time (years since menopause or age) taking into account the intra-subject correlation of the 
measurements. The effect of BMI as a continuous variable was included into the model as a 
time-varying covariate. Thus, the statistical model implicitly accounts for the cyclical 
changes of BMI. The alternative available techniques, such as repeated measures of 
ANOVA, would have oversimplified the results. Some of the covariates (grip strength, 
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diseases and medications affecting bone, smoking and calcium intake) were adopted from 
baseline data, which reduces their accuracy in the analyses. Maximum grip strength value 
of the dominant hand may differ from measurement values adopted with the three 
successful measurements of right hand grip strength values used in the present study. 
However, both the maximum grip strength and the mean of three successful values are 
considered as methodologically valid and reliable (Bohannon et al. 2007). 
6.2 DISCUSSION OF RESULTS 
6.2.1 The effect of adiposity on cross-calibration between two different DXA devices (I) 
If adiposity is not taken into account during regular in vivo cross-calibration between two 
different DXA devices then this could well lead to false conclusions (Blake, Harrison & 
Adams 2004). In the present cross-calibration of the older DPX and the newer DPX-IQ 
densitometers, obesity affected hip, but not spinal results. Interestingly, spine is generally 
considered more sensitive to fat related inaccuracies (Bolotin 1998, Bolotin, Sievanen & 
Grashuis 2003). The image resolution of newer DXA modalities has improved significantly 
from that achieved with the older DXA densitometers (Mazess et al. 2000, Blake, Harrison 
& Adams 2004). Compared to older pencil-beam DPX-L device the newer fan-beam 
Prodigy overestimated the total body mass and total body BMD at high bone density 
(Huffman et al. 2005). Importantly, 40% of the variance in the difference of measured spinal 
BMD values by DPX-L and Prodigy devices could be explained by systematic differences in 
body weight and body soft tissue composition measured with the devices (Blake, Harrison 
& Adams 2004). In conclusion, significant differences may exist between different 
densitometers even from the same manufacturer. A phantom-based cross-calibration does 
not adequately correct for site-specific differences between the instruments. Thus, adiposity 
needs to be taken into account during in vivo cross-calibration. In all ROIs, including the 
trochanter BMD ROI, the slopes of the regression lines were significantly different from 
unity, emphazing the need for the application of correction equations between the two 
densitometers. According to ISCD correction coefficients are needed if the difference 
between the values of the two densitometers exceeds 1% (Shepherd et al. 2006). Thus, 
correction between DXA devices is not compulsory as the difference between DPX and 
DPX-IQ densitometers in trochanter BMD values was only 0.1%. However, also in 
trochanter ROI, closer agreement was observed in BMD values between DPX and DPX-IQ 
devices after simple and multivariate correction coefficients were applied compared to 
original values. 
Furthermore, both body composition and bone mineral estimates by different DXA 
devices are known to vary (Blake, Harrison & Adams 2004). Thus, the present results 
cannot be extrapolated to DXA devices from different manufacturers or even to different 
devices from the same manufacturer. Furthermore, the calculated correction equations 
between DPX and DPX-IQ devices from the present study might not be equally 
interchangeable when other DXA devices are in use. Indeed, there may be considerable 
differences even between similar devices from the same manufacturer due to differences in 
calibration, detector-problems or errors after maintenance (Gaither et al. 1996). Importantly, 
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regular phantom measurements can detect any drift in machine calibration (Shepherd et al. 
2006). 
6.2.2 The current role of adiposity in DXA, pDXA, and QUS measurements (II) 
It is well known that both DXA and QUS techniques are affected by adiposity-related 
artifacts (Chappard et al. 2000, Javed et al. 2009). Furthermore, overweight protects from 
osteoporosis (Stewart et al. 2006, Reid 2010). According to the present study (II) there may 
be considerable variation in how adiposity affects the results between different devices and 
techniques. The effect of adiposity on central DXA, pDXA and QUS values has not 
previously been examined. The association between anthropometrical measurement values 
and heel QUS parameters (i.e. BUA and SOS) remains somewhat controversial. Some 
studies indicate that both BUA and SOS values (including GE Lunar Achilles QUS) may be 
associated with anthropometrical parameters (Stewart et al. 2006, Brunner, Pons-
Kuhnemann & Neuhauser-Berthold 2011). In contrast, in the present study Achilles-
measured heel BUA values were associated with adiposity, whereas none of the 
anthropometrical parameters were associated with heel SOS values. However, some studies 
have reported that anthropometrical values are typically associated with BUA but not with 
SOS values (Hologic Sahara QUS) (Schoffl et al. 2008, Kauppi et al. 2009). Furthermore, the 
present results are in accordance with the results of Stewart et al. that stiffness index values 
were associated with higher body weight and FM (kg), but in the present study (II) the 
stiffness index was not associated with relative (%) FM (Stewart et al. 2006). Thus, it seems 
that overall adiposity is associated with higher BUA values, whereas the association 
between adiposity and SOS values is somewhat obscure and may partly depend on the 
QUS device being used. In contrast, an increase in the local heel fat thickness may 
underestimate heel SOS, but not BUA parameters (Hausler, Rich & Barry 1997). 
Unfortunately, no measurements were available for either os calcis width or local heel soft 
tissue thickness in the present study II. However, after adjustment for heel BMD (as a crude 
surrogate estimate of bone size), heel BUA was no longer associated with the relative (%) 
total-body FM, whereas an inverse relationship was found between the heel SOS and 
adiposity. There are also inconsistent results regarding the effect of LBM on QUS 
parameters. Brunner et al. suggested that it is LBM rather than FM which can affect QUS 
parameters in elderly women (GE Lunar, Achilles) (Brunner, Pons-Kuhnemann & 
Neuhauser-Berthold 2011). In contrast, LBM was associated with QUS parameters (Hologic 
Sahara) in premenopausal women, but not in postmenopausal women (Saadi et al. 2003). In 
the present study (II) LBM (kg) was not associated with any QUS parameters. 
In the present study (II) increasing adiposity was associated with higher pDXA-
measured normalized heel BMD values similar to those measured by central DXA in 
lumbar spine ROI. However, higher BMD values were observed with increasing adiposity 
especially in lumbar spine ROI in the present study (II). Consequently, DXA technology 
seems to overestimate especially spinal BMD values as obesity becomes more marked 
(Bolotin 2004). However, the Prodigy-DXA device was less prone to BMD errors 
attributable to excess soft-tissue thickness, being clearly superior to older DXA machines 
(Mazess et al. 2000). According to the meta-analysis conducted by Ho-Pham et al. of the 
body composition parameters LBM is the main determinant of femoral neck and lumbar 
spine BMD values in both men and premenopausal women, whereas in postmenopausal 
women both LBM and FM are positively associated with femoral neck (e.g. LBM, r=0.33 and 
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FM, r=0.31) and lumbar spine (e.g. LBM, r=0.34 and FM, r=0.31) BMD values (Ho-Pham, 
Nguyen & Nguyen 2014). In the present study (II) both LBM (kg) and FM (kg) were 
associated with femoral neck (e.g. LBM, r=0.23 and FM, r=0.23) and lumbar spine (e.g. LBM, 
r=0.21 and FM, r=0.39) BMD values, whereas relative (%) FM was only associated with 
lumbar spine (r=0.34), but not with femoral neck (r=0.15), BMD values. Furthermore, if both 
body composition parameters (FM and LBM) were included in the same multivariate linear 
regression model, then LBM (kg) was the only determinant of femoral neck BMD values 
and FM (kg) was the only determinant of lumbar spine BMD values. Thus, especially 
higher adiposity seems to be associated with higher DXA, pDXA and QUS values in the 
present study, but it is important to prevent sarcopenia as higher LBM was positively 
associated with clinically important femoral neck BMD values. It is difficult to assess the 
extent to which the discrepancies between different ROI’s and adiposity are of biological 
origin (Mendez et al. 2012). However, it is important to note that adiposity affects the 
results and, consequently the same individual might be over- or underdiagnosed 
depending on the equipment in use (Javed et al. 2009). Finally, according to present study 
(II) weight seems to be the strongest determinant of DXA, pDXA and QUS parameters 
(except heel SOS) of all anthropometrical parameters (i.e. FM, LBM, %FM, weight, BMI and 
height). 
In the present study, the devices were from the same manufacturer. However, there were 
inconsistencies in T-score and normalized (z-score) values especially between the 
peripheral and central devices when they were used in the present study population. These 
inconsistencies cannot be explained by fat-related measurement errors or biological 
differences. Therefore, there are also extra problems related to use of different reference 
populations for normalization (Blake, Fogelman 2009). The same study sample should be 
measured with different devices to ensure an optimal and unbiased comparison between 
devices. In conclusion, the effects of adiposity on DXA, pDXA and QUS parameters may 
differ significantly depending on the device and manufacturer selected. 
6.2.3 The effect of central obesity and HT on bone densitometry (III) 
In the present study, central distribution of body fat (i.e. trunk fat) was associated 
especially with spinal, not with hip, BMD values. As described in the review of the 
literature, there are several biological reasons that may link together central adiposity and 
bone density positively. For example, centrally obese women have high estrogen, 
testosterone, leptin and lower adiponectin levels as well as exposing their bones to higher 
mechanical loading compared to leaner women (Biver et al. 2011, Liedtke et al. 2012). 
Unfortunately, hormone levels were not measured in the present study. The relative 
proportion of trabecular bone is much higher in the lumbar spine (60-95%) compared to 
that in the greater trochanter (50%) and femoral neck (25%) (Riggs et al. 1982, Wells et al. 
2002). 
However, especially in the lumbar spine, increasing adiposity inside and adjacent to the 
bone may reduce X-ray beam attenuation and thus overestimate the BMD (Bolotin 2007). 
On the other hand, the Prodigy device, used in the present study, may be less prone to 
errors attributable to excess soft-tissue on BMD measurements as compared to older 
equipment (Mazess et al. 2000). It was not possible with the DXA technology used at the 
time of the present study to separate VAT and SAT in the way now possible with iDXA or 
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Prodigy densitometers running enCORE software. Therefore, the results obtained in the 
present study may not completely reveal the true relationship between VAT and BMD. 
Furthermore the validity of the DXA-measured trunk-leg fat ratio for measuring central 
obesity has not been adequately established (Zillikens et al. 2010). However, there is a 
relatively good correlation between CT and DXA-measured abdominal fat (Snijder et al. 
2002). Different surrogate measures for the relationship between central obesity and BMD 
have shown inconsistent results. More sophisticated methods, such as CT or MRS, have 
consistently revealed the detrimental effect of VAT on premenopausal BMD values (Sheu, 
Cauley 2011). Moreover, obesity may be associated with a higher vertebral fracture risk in 
postmenopausal women (Pirro et al. 2010). Thus, the positive association between central 
obesity and BMD may at least partly reflect the methodological limitation of DXA 
technology. However, trunk fat as measured by DXA contains both SAT and VAT, which 
may explain also the positive association between spinal BMD and trunk fat (Bredella et al. 
2010). 
Is obesity acceptable from a medical perspective? Optimisation of peak bone mass 
should be the cornerstone in efforts to prevent osteoporosis and subsequent fractures 
(Mughal, Khadilkar 2011). Further research is needed to clarify the association between 
childhood obesity and accrual of peak bone mass, however obesity and a sedentary lifestyle 
cannot be recommended in children or early adulthood (Mughal, Khadilkar 2011). Even 
though obesity and overweight are associated with higher BMD (Mendez et al. 2012), these 
conditions also may also be linked associated with an increased risk of osteoporosis (Greco 
et al. 2010). Similarly, the increasing prevalence of obesity in the population has not 
necessarily been associated with a significant reduction in the number of osteoporotics 
(Looker, Flegal & Melton 2007). Furthermore, a higher BMI and more fat do not 
proportionally elevate bone strength (Sornay-Rendu et al. 2013). The relative bone strength 
index of tibia was inversely associated with adiposity, but not with LBM, in three 
generations of Finnish women (Xu et al. 2010). The ability of the tibia to support excess 
weight of fat was worse in pre- and postmenopausal women as compared to the situation 
in girls due to lower periosteal apposition which is needed to increase diaphyseal width 
(Xu et al. 2010). Sarcopenia and osteoporosis are linked together (Sirola, Kröger 2011). 
Obese adults are believed to have a higher falling tendency, lower physical activity and 
function levels (Beck et al. 2009). Furthermore, obesity is sometimes associated with low 
muscle mass, hence, the term sarcopenic obesity (Dupuy et al. 2013). In some individuals, 
obesity may be regarded as a “high-caloric state of malnutrion” but also dieting may be 
associated with nutritional deficiencies (Wells 2013). For example, obesity is often 
associated with vitamin D deficiency (Vimaleswaran et al. 2013). However, overweight 
subjects are less prone to osteoporotic fractures (De Laet et al. 2005b). On the other hand, 
hip protectors and compliant flooring materials will also decrease the impact force and 
fracture risk (Laing et al. 2011, Li, Tsushima & Tsushima 2013). Only about 30% of obese are 
spared from metabolic complications (Bluher 2012). But even in those cases obesity is 
associated with significant co-morbidity (Forte et al. 2012). Especially men as well as 
postmenopausal and elderly women are at risk of accumulating VAT in comparison to 
premenopausal women (Nedungadi, Clegg 2009, Shi, Clegg 2009). Central adiposity as 
measured by DXA has been positively associated with BMD in postmenopausal women 
(Zillikens et al. 2010). However, VAT and bone marrow fat have been shown to have 
negative effects on bone when this is assessed with more sophisticated methods (Sheu, 
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Cauley 2011). Women are not spared from the other co-morbidities associated with VAT 
(Shi, Clegg 2009). Thus, across the human lifespan obesity seems to be more detrimental 
and is therefore not desirable in most cases. The increased risk of suffering the many other 
co-morbid conditions outweighs the protective effects that being overweight confers on 
avoiding osteoporosis and subsequent fractures (Forte et al. 2012). 
Should we encourage people to be thin or underweight? Anorexia nervosa is associated 
with lower BMD and severe medical complications (Misra, Klibanski 2011). Most hormonal 
and metabolic disturbances return to normal values after renutrition in anorexic patients 
(Howgate et al. 2013). However, especially the thinnest individuals are at risk of developing 
osteoporosis and subsequent fragility fractures (Dargent-Molina et al. 2000, Fernandez-
Garcia et al. 2009). For example, even a 5% weight loss especially in relatively thin middle-
aged individuals increases the fracture risk (Langlois, Mussolino et al. 2001). The 
association between mortality and weight is j- or u-shaped, thus malnutrition and thinness 
across the lifespan is a serious health concern (Wahlqvist, Chuang 2012) i.e. being 
underweight is not recommendable. 
Thus, ideally maintaining a healthy body weight is a good strategy for bone health 
because huge swings in body weight and weight loss lead to enhanced bone loss (Villalon 
et al. 2011). Should some people gain weight? Anorexia nervosa is associated with an 
increased amount of VAT and bone marrow fat, whereas weight gain improves body 
composition parameters (Fazeli et al. 2012). For the thinnest postmenopausal women, who 
are at a greater risk of osteoporosis and fragility fractures, it may be advisable that they 
should gain some weight, preferably by increasing muscle mass and secondly by increasing 
SAT (De Laet et al. 2005a, Rikkonen et al. 2010). Should some people abstain from weight 
loss? In the oldest (≥80 years) and in frail individuals, it may be advisable to abstain from 
recommending weight loss (Darmon 2013). Who should lose weight? In overweight or 
obese individuals, a weight reduction of 10% or more is recommended due to the reduction 
this achieves in co-morbid risk factors (Barte et al. 2010). In the elderly, weight loss is 
especially important in obese individuals with co-morbid conditions or functional 
impairments (Mathus-Vliegen 2012). 
What is the role of exercise? Physical activity is associated with less sarcopenia less bone 
loss and conversely inactivity whether caused by immobilization or a sedentary lifestyle 
has been shown to reduce LBM and BMD values (Sutton et al. 2009). The physical activity 
level is inversely associated with BMI (Langsetmo et al. 2012). A greater muscle mass is 
linked with better balance and this reduces falls associated with osteoporotic fractures 
(Shapses, Sukumar 2012). Immobilization seems to be more detrimental in the elderly than 
in younger subjects (Hvid et al. 2010). A vicious circle is evident because low BMD and 
osteoporotic fractures increase the risk of immobility (Shiraki et al. 2010). Muscle work 
causes dynamic loads, which promote bone formation more than a mere static load due to 
overweight, although fat may indirectly affect the amplitude of the stimulus (Pfeifer et al. 
2004). Exercise also improves physical function during weight loss in older obese adults 
(Villareal et al. 2011). However, in anorectic patients, exercise does not improve BMD 
(Waugh et al. 2011). Strength exercise, multi-component exercise (strength, aerobic, high 
impact and/or weight-bearing training) and whole-body vibration have been found to 
improve bone health (Gomez-Cabello et al. 2012). In contrast, walking is less effective for 
preventing bone loss and during slippery weather it is recommended that the individuals 
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should wear to use anti-skid devices on their shoes to prevent falls and activity fractures 
such as wrist fractures (Rikkonen et al. 2010, Gomez-Cabello et al. 2012). Especially in 
elderly people, an evaluation of bone health before embarking on an exercise program 
might be advisable, because heavy lifting is a risk factor for spinal compression fractures 
(Wolfram, Wilke & Zysset 2011). 
What should be taken into account during a weight loss program in osteoporosis and 
sarcopenia point of view? For example, around 500 kCal deficiency/day is recommended in 
elderly (Mathus-Vliegen, Obesity Management Task Force of the European Association for 
the Study of Obesity 2012). Thus, if weight loss is necessary for improving cardiovascular 
or general health, then adequate protein (1 g/kg/day) and calcium supplementation (1.7-1.8 
g/day) as well as a regular exercise protocol should be included in the weight loss program 
in order to attenuate bone loss secondary to weight loss (Shapses, Sukumar 2012). Vitamin 
D, adequate protein intake and exercise can also prevent occurrence of sarcopenia (von 
Haehling, Morley & Anker 2012). Obese individuals may need higher doses of vitamin D 
supplements to achieve the same vitamin D level compared to leaner subjects (Gallagher, 
Yalamanchili & Smith 2012). Vitamin D and calcium may also help in weight management 
(Soares et al. 2012). HT is also known to attenuate weight loss-related bone loss; however 
the risks and benefits of HT need to be carefully assessed before initiation of HT for 
reducing bone loss during weight reduction program (Sirola et al. 2003, Howgate et al. 
2013). Both estrogen therapy and bisphosphonate therapy may reverse the BMD loss 
associated with anorexia nervosa (Howgate et al. 2013). 
In the present study the effect of central obesity on BMD was not modified by the use of 
HT. There are no previous studies investigating the interaction between HT, central obesity 
and BMD. Users of HT are generally healthier than non-users (Grimes, Lobo 2002) and this 
was also found in the present study. Users of HT were thinner and had less abdominal fat, 
which is in accordance with most previous studies (Salpeter et al. 2006). However, due to 
the cross-sectional nature of the present study, it is not possible to rule out a selection bias 
as the effects of HT on body composition and weight were not followed up prospectively 
(Bhandari et al. 2003). 
6.2.4 Overweight and progress of bone loss (IV) 
The observed protective effect of overweight, especially against lumbar spine osteopenia in 
the present study, may not reflect the entire truth, as both conditions i.e. overweight and 
underweight cause measurement inaccuracies in BMD i.e. overestimating and 
underestimating BMD values, respectively (Bolotin 2004). Thus, the protective effect of 
overweight against spinal bone loss would be reduced if DXA devices were not affected by 
fat-related artefacts (Bjarnason, Christiansen 2000, Bolotin 2004, Mendez et al. 2012). In 
contrast to some previous studies (Hannan et al. 2000, Macdonald et al. 2005), in the present 
study the absolute bone loss rate was not affected by the presence of obesity. Of course one 
must keep in mind that the relative bone loss rate of 3% would absolutely correspond to a 
bone loss of -0.015 g/cm2 from an initial BMD level of 0.5 g/cm2 and -0.030 g/cm2 from a 
value of 1.0 g/cm2. It is possible to estimate the effect of weight change on BMD results with 
the help of the prediction models used in the present study. However, especially during 
times when body weight is changing, the reliability and precision of planar DXA 
measurements may be diminished (Bolotin, Sievanen & Grashuis 2003). Inherent errors 
associated with body thickness and DXA technology as well as the relatively low number of 
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underweight and morbidly obese women in the present study limits the ability to estimate 
the extent of bone loss in extreme cases. Furthermore, comparison of T-score results based 
on manufacturers’ reference data between Lunar DPX and Hologic QDR-1000/W showed a 
mean difference of -0.9 SD for femoral neck BMD (Faulkner, Roberts & McClung 1996). The 
mixed models used in the present study IV are less prone to regression towards the mean 
when compared to less sophisticated methods for analysing repeated measures of 
longitudinal data (Peduzzi et al. 2002). The number of osteoporotics at the hip ROI might 
differ significantly between manufacturer-based reference values compared to NHANES 
normative database (Blake, Fogelman 2009). 
The rapid perimenopausal spinal bone loss was confirmed also in the present study 
(Mazzuoli et al. 2000, Finkelstein et al. 2008). Similarly, a cessation of rapid bone loss has 
been observed during later menopause (Mazzuoli et al. 2000, Finkelstein et al. 2008). In the 
present study, AP lumbar spine BMD values increased after 15 postmenopausal years 
similarly to findings of Liao et al. (Liao et al. 2003). According to NHANES, spinal bone loss 
seems to reach a plateau or even to increase in women over 70 years of age (Looker et al. 
2012c). CT-derived spinal BMD also seems to plateau in the elderly similar to DXA 
measurements (Blake, Fogelman 2009). In contrast, some studies have not detected any 
increase in spinal BMD values in elderly women (Hammoudeh et al. 2005, Larijani et al. 
2005). However, this may not accurately reflect the actual skeletal situation in the elderly 
due to inherent errors of planar DXA technology that may result in artefactual minor 
changes in the scan area (Gregson et al. 2013). Thus, there might have remained some 
artifacts such as minor degenerative changes or vertebral compressive fractures unobserved 
in the present study. It is not known whether improved algorithms and resolution of 
modern DXA technology are less prone to artefacts attributable to degenerative processes 
in the spine (El Maghraoui, Roux 2008). Thus, the risk for falsely elevated AP spinal BMD 
values should be taken into account, especially in the elderly (Gregson et al. 2013). The 
recommended site for osteoporosis diagnosis in late postmenopausal women is the 
proximal femur (Lewiecki et al. 2008). In accordance with previous studies, a steady 
progressive age-related cortical femoral neck bone loss was apparent in postmenopausal 
and elderly women (Looker et al. 2012b). Indeed, plain radiographs and other techniques 
such as visual semiquantitative technique assessment or digital computerized 
morphometry of the spine may be helpful in revealing undetected spinal fractures (Difede 
et al. 2010). Trabecular bone predominates at the spine whereas cortical is the major bone 
form at the femoral neck, and this might explain the observed differences in the bone loss 
rate between the femoral neck and the spine during the period of estrogen depletion in the 
perimenopausal women (Riggs et al. 1982, Wells et al. 2002). 
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7 Suggestions for future research 
Some future research plans have emerged on the basis of this thesis. Future experiments 
could: 
 
1. Examine whether adiposity affects the cross-calibration of other commercial 
DXA-instruments. 
 
2. Clarify the association between Lunar iDXA-measured VAT and BMD values. 
 
3. Quantify the relative importance between body composition and densitometric 
parameters. 
 
4. Analyse the relationship between obesity, osteoporosis and fragility fractures. 
 
5. Study whether alternative osteoporosis medications other than HT could 
reduce weight loss induced bone loss. 
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8 Conclusions 
1. Adiposity should be taken into account in in vivo cross-calibration between 
different DXA devices. 
 
2. DXA, pDXA, and QUS parameters were differently affected by adiposity. 
 
3. Postmenopausal women with central body fat distribution are associated with 
higher spinal BMD, but not with hip BMD, regardless of HT use. 
 
4. Overweight may delay the incidence of spinal and hip osteopenia considerably. 
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Dual-energy X-ray absorptiometry 
(DXA) is commonly used to 
diagnose osteoporosis. Overweight 
is considered to confer protection 
against from osteoporosis, but 
DXA devices may be subject to 
systematic errors when they are 
measuring overweight individuals. 
This study aimed to assess how 
obesity can affect bone mineral 
measurements.
